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Abstract 
Namibia is severely affected by the HIV/AIDS epidemic, with an estimated HIV prevalence 
of 17.8%. A comprehensive, public HIV/AIDS treatment and care programme was 
established in 2003 by the government of Namibia in association with its development 
partners. The introduction of antiretroviral therapy [ART] has dramatically decreased HIV-
related mortality and morbidity, improved quality of life, revitalized communities and 
transformed perceptions of HIV/AIDS from a plaque and death sentence to a manageable 
chronic condition. Intermediate Hospital Oshakati (IHO) in the Oshana region, is one of the 
six pilot hospitals where highly antiretroviral therapy (HAART) was initiated. 
Adherence to antiretroviral therapy (ART) is a key factor in ensuring optimal clinical 
outcomes and is associated with improved survival among HIV and AIDS patients. Sustained 
high levels of adherence (taking 95% or more of medication as prescribed) are essential for 
treatment success. Suboptimal adherence to treatment has been associated with virologic, 
immunologic and clinical failure, and may increase the risk of resistance to first-line ART 
drugs. 
Studies conducted in various parts of the country including the Oshakati district, report small 
proportions of patients defaulting on ART. Defaulting from treatment raises questions about 
adherence to ART as it can be assumed that poor adherence would precede defaulting from 
treatment. This study explored factors that influence poor adherence to ART among patients 
at Intermediate Hospital Oshakati. 
 
Methodology 
An explorative, qualitative study was conducted. In-depth interviews were conducted with 12 
patients from the Communicable Disease Clinic (CDC) at Intermediate Hospital Oshakati 
who were identified as poor adherents. This data was triangulated with four key-informant 
interviews with health-workers in the facility. Data were audio-tape recorded and transcribed 
verbatim. Thematic and content analysis was done. 
 
Results 
The reasons given by the participants for defaulting on their treatment included social factors 
such as spiritual beliefs, cultural beliefs, stigma and discrimination  contributed patients first 
seek traditional healers’ opinions before consulting health-worker, non-disclosure of HIV 
status and unwillingness to take medication in the presence of others. Patient related factors 
such as poor understanding of treatment regimen, forgetfulness, alcohol use, lack of 
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commitment, travelling and illiteracy affected the level of adherence to ART adherence. The 
health service related factors such as poor patient-health provider relationship, negative 
attitudes of health providers and long distance to health facility were reported to have 
influenced non adherence.  
Unemployment and unavailability of transport were major socio-economic factors that led to 
defaulting. In addition the findings of the study show work related factors such as work 
related pressure, together with lack of employers support, as well as treatment related factors, 
such as treatment side-effects and treatment fatigue, to have contributed to defaulting.  
 
Conclusions 
People living with HIV/AIDS are still facing major social challenges such as stigma and 
discrimination by family members and the community as well as at work, and these hamper 
adherence. Illiteracy contributes to poor understanding about the importance treatment 
adherence leading to non-adherence. Therefore in order to improve adherence in communities 
a lot of effort needs to be put on literacy to enable patients have a better understanding about 
treatment adherence. 
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CHAPTER 1: INTRODUCTION 
 
1.1 Global overview of the HIV epidemic 
The world at large is facing an unrivalled public health crisis as HIV and AIDS are reported 
to have reached every corner of the globe and continues to spread disproportionately fast in 
marginalized populations in most countries (WHO, UNAIDS & UNICEF, 2009). The number 
of people living with HIV worldwide continued to grow reaching an estimated 33.3 million in 
2009, which was more than 20% higher than the number in 2000. It is further estimated that 
2.6 million new infections and 1.8 million AIDS-related deaths occurred worldwide in 2009. 
The latest epidemiological data indicate that the spread of HIV appears to have peaked in 
1996 when 3.5 million new HIV infections occurred (UNAIDS/WHO, 2010). Africa remains 
the global epicenter of the AIDS epidemic, with Sub-Saharan Africa being the worst affected 
region (UNAIDS, 2011). In 2010 about 68% of all people living with HIV resided in Sub-
Saharan Africa and accounted for 70% of new infections. 
 
1.2 Burden of HIV and AIDS in Namibia 
In 2008 the Namibian population was estimated around 2.1 million; of these 230,000 were 
estimated to be infected with HIV giving a national prevalence of 17.8% the estimated 
population life expectancy was 52 years (MOHSS, 2008). HIV is considered a public health 
problem in Namibia since the prevalence ranges from 6% at Opuwo, Aranos and Rehoboth 
district to 32% at Katima Mulilo District. The Oshana region, where the study was 
conducted, is one of the regions in the country with a high HIV prevalence rate of 22.4% 
among pregnant women (MOHSS, 2008). 
 
HIV has a major impact on the economy of the country and social progress leading to 
poverty, a reduction in life expectancy and contributing to food shortage (Jackson, 2002). 
Although the current HIV sentinel survey in Namibia shows a decline in HIV prevalence 
from 22% in 2002, to 17.8% in 2008, HIV still remains the major cause of death in the 
country accounting for 23% of all reported deaths and for 41% of deaths in the age group 15 
to 49 years (MOHSS, 2008). A high prevalence of HIV infection in the economically 
productive age group (25-35 years) diminishes productivity and exacerbates food insecurity, 
making HIV not only a health issue but an economic and development challenge as well 
(UNAIDS, 2008).  
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1.3 HIV/AIDS treatment 
 
The introduction of Highly Active Antiretroviral Therapy (HAART) in 1996 was a turning 
point for hundreds of thousands of people who had access to the treatment (MOHSS 2007 a). 
Although HAART cannot cure the disease it has dramatically reduced mortality, prolonged 
lives, and improved the quality of life of many people living with HIV/AIDS. HIV has 
transformed from a rapidly progressive and universal fatal disease to a chronic and often 
stable condition (Arnsten et al., 2007; Mills et al., 2006).  
According to the Ministry of Health and Social Services (2006), after the introduction of 
ART in Namibia positive outcomes were noted such as a decrease in hospital admissions 
from 12,852 in 2004 to 11,410 in 2005; and a decrease in AIDS-related deaths from 3,6627 in 
2004 to 3,230 in 2005.  
 
1.4 Adherence  
Despite the fact that antiretroviral therapy (ART) improves the lives of those infected with 
the HIV worldwide, ART programs are faced with a major challenge of lack of adherence to 
treatment (WHO, 2003). Suboptimal adherence to treatment may result in reduced treatment 
efficacy from increased viral replication, leading to the development of viral mutations, and 
the spread of drug resistant HIV which is treated with second-line/or third-line medications 
that are associated with many side-effects and are more expensive than first line drugs 
(Peltzer et al., 2010; Paterson et al., 2000). According to authors there is a high risk of 
treatment failure amongst those taking less than 90% of the prescribed dose. (Arnsten et al., 
2007; MOHSS, 2007b; Castro, 2005). Antiretroviral medication adherence is absolutely vital 
for the success of HAART. There is consensus that in order to achieve sustained suppression 
of HIV growth over time, and to prevent the development of drug resistance a very high level 
of adherence, taking at least 95% of prescribed doses, is required. Lower levels of ART 
adherence provide a temporary clinical benefit but pose a very high risk of developing 
resistance and treatment failure (MOHSS, 2007b; Castro, 2005; Paterson et al., 2000).  
The first steps towards effective treatment are to make proper diagnoses of the illness and 
identify the appropriate treatment. However, medication adherence is an equally important 
component of the treatment because even the most effective medication will not work if taken 
incorrectly (Bogart et al., 2000). 
 
 
 
 
3 
 
 
Access to ART in Sub-Saharan Africa has improved during the last decades by implementing 
the WHO guidelines that promote task shifting to less specialized health-care workers 
(UNAIDS/WHO, 2009). Nonetheless Sub-Saharan Africa is still facing a challenge to 
achieve adherence since it has high rates of HIV/AIDS infection compared to other low 
income regions. It is reported that there is growing evidence of high rates of patient loss to 
follow-up. In Africa an ART program retains only about 60% of patients after two years on 
ART (Rougemont et al., 2009).   
 
To ensure proper adherence to treatment regimen the following factors are important: 
  taking all the pills at the right time in the correctly prescribed doses and in the right 
way,  
 taking all the pills makes up the correct quantities of the ARV combination, 
  taking the medications at the right time: failing to take medication at the right time 
may cause a rise in viral load which can contribute to development of drug resistance, 
  taking medications in the right way: medications may require to be taken with food 
or without food to ensure proper absorption by the body. Some medications are better 
absorbed on an empty stomach and some on a full one. In addition eating the right 
kind of food might be required since some of the medications are absorbed with fat 
and eating some fat can make a difference,  
  interaction with other drugs or medications needs to be checked since some drugs can 
have potentially dangerous interaction with ARVs. 
 
1.5 Access to antiretroviral therapy in Namibia 
According to MOHSS (2007 a), HIV/AIDS was once perceived as a death sentence but with 
the discovery of more potent and efficacious medicines it is turned into a chronic disease. In 
Namibia the use of highly active antiretroviral therapy (HAART) was introduced in the 
public health sectors in 2003 (MOHSS, 2007a). By the end of December 2010 there were 
89,494 patients on ART in public hospitals with adults constituting 89% and pediatrics 
10.2%; it is estimated that at the current growth rate the total number of patients on ART is 
expected to reach 100,000 by June 2011 (MOHSS, 2010). The government rapidly scaled up 
the treatment since then, and by 2010 all 44 public hospitals provided ART.  
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The nationwide programme that provides ART in public health facilities was launched in 
2003 by the Namibian Ministry of Health and Social Services (MOHSS) in conjunction with 
international partner (MOHSS, 2007b). Initially patients were required to pay a small user 
fees but this was abolished in 2007 to increase access to treatment. Currently HIV treatment 
is free of charge to patients in all public health facilities including the Intermediate Hospital 
Oshakati (IHO). The roll-out of free ART services was extended to all 34 state hospitals in 
Namibia in 2010. Since the introduction of the ART services there has been a massive uptake 
of them by eligible patients.  
To ensure optimum ART outcomes, appropriate use of medicines is required as it is 
imperative that patients adhere to treatment as per doctor’s instructions. Adherence to 
treatment is a challenging process that requires input and support from all role players 
including the patient, health care providers, family members, the community, employers and 
the health system (Fomundam, 2008). 
 
1.5.1 Social eligibility criteria for starting antiretroviral treatment in Namibia 
In addition to the clinical and immunological criteria, that were set up by the WHO to guide 
clinical decisions for initiating prophylaxis and starting ART, the Namibian Ministry of 
Health and Social Services (MOHSS) has established social criteria which must be met by an 
individual before ART can be started. The purpose of these criteria, which are listed below, is 
to maximize adherence and reduce the risk of patients defaulting and to minimize the 
possibility of development of resistance (MOHSS, 2007b). These criteria include an HIV 
positive individual who: 
 Must have lived at a fixed address for more than three months. 
 Must have ready access to a designated treatment centre for follow-up. 
 Must not drink alcohol. 
 Must not have untreated underlying psychiatric disorders. 
 Should be committed to lifelong treatment of ART, adherence, practicing 
safer sex and allowing home visits as indicated (MOHSS, 2007b).  
 
1.5.2 Clinical eligibility for antiretroviral treatment 
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ART initiation in adults and adolescents are done in accordance with the WHO clinical stages   
recommendations and the availability of immunological markers, (MOHSS 2007b). The 
WHO clinical staging of HIV is as follows: 
 
1. WHO Clinical Stage I (Asymptomatic) 
During this stage the patient is asymptomatic or may have persistent generalized 
lymphadenopathy, the person feels well and can perform all the normal activities. 
 
2. WHO Clinical Stage II (Mild disease) 
At this stage person has unexplained moderate weight less than 10% of body weight, 
recurrent upper respiratory tract infections and may present with conditions such as angular 
cheilites, recurrent oral ulceration, herpes zosters and popular pruritic eruptions. 
 
3. WHO Clinical Stage III (Advanced Disease) 
At this stage the person presents with unexplained severe weight loss over 10% of the 
presumed or measured body weight, unexplained chronic diarrhoea for longer than a month, 
persistent fever, pulmonary tuberculosis as well as severe bacterial infections. 
 
3. WHO Clinical Stage IV (HIV wasting syndrome) 
At this stage the person is clinically very sick and no longer productive, and presents with 
various opportunistic infections. 
 
1.5.3 Methods to achieve readiness to start HAART and maintain adherence 
According to the Namibian National Guidelines for Antiretroviral Therapy, patients who are 
eligible for HAART have to undergo a period of education and preparation to maximize 
future adherence (MOHSS, 2007b). During these preparations the patients are informed about 
commitment to lifelong therapy, the importance of medication adherence to a successful 
outcome, the need to maintain safer sexual practices to prevent HIV transmission, and the 
need to report any side-effects of the medications. If a patient is not fully committed to 
adhering to therapy at the time of initiation then treatment is delayed until all the 
shortcomings are addressed. When the treatment is started ongoing patient health education is 
necessary as well as continued monitoring of adherence. Continuous reinforcement of 
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adherence throughout the entire course of HAART is very essential. Patients are expected to 
receive care at a communicable disease clinic nearest to their homes, but if they are away 
from home they should not be denied care or medication refills (MOHSS, 2007b).  
 
1.6 Problem statement  
According to the Ministry of Health and Social Services (2006), 95% of the patients enrolled 
in the ART programme since 2003 in Namibia were still alive in 2006, 4% died and 1% 
defaulted. At the IHO’s Communicable Disease Clinic 9,549 patients were registered on ART 
during the period May 2004 to March 2009, and 587 (6.1%) defaulted from treatment over 
this period (Heath Information System (HIS), 2009). Since the programme started at IHO 
there are no documented studies to assess the clients’ response to treatment and challenges 
they face with respect to adherence. Furthermore the abovementioned situation with 
defaulting raises questions about adherence because it can be reasonably assumed that poor 
adherence would precede defaulting. Thus, an even greater proportion of patients are not 
adhering optimally, though not altogether lost to follow-up. There was therefore a need to 
conduct a systematic investigation into the factors that influence poor adherence among 
patients in the Oshana District. 
 
1.7 Outline of the thesis 
Chapter 1 introduces the study and includes the formulation of the problem statement and 
rationale for the study. 
Chapter 2 focuses on the review of the relevant literature on treatment adherence. 
Chapter 3 explains the research methodology, namely, the aim and objectives, the research 
design, the study population, sampling, data collection, data analysis, methods for ensuring 
rigor and ethical considerations. 
Chapter 4 presents the study results. 
Chapter 5 discusses the findings of the study and limitations of the study. 
Chapter 6 presents recommendations and conclusions. 
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CHAPTER 2: LITERATURE REVIEW 
2.1 Introduction 
This chapter discusses the literature on adherence to antiretroviral therapy (ART) and the 
factors that influence adherence. The researcher conducted an extensive literature review on 
the factors that are used to manage adherence, namely, religious, cultural, community and 
family related factors, patient related factors, socio-economic factors, health service related 
factors, and traditional factors as well as work place related factors. This chapter concludes 
by highlighting theories that explain the management (treatment) of defaulting behaviors. 
 
2.2 Definition of concepts 
2.2.1 Adherence to antiretroviral therapy 
Adherence means to stick to or to follow a prescribed health regimen which could be a 
medication, a special diet, or to abstain from certain drugs or an exercise regimen. Adherence 
to treatment is defined as the extent to which a patient takes prescribed medications according 
to the instructions given by a health professional (McDonald, Garg & Hynes, 2009; Osterberg 
& Blaschke, 2005; Rabin, El-Sadr & Abrams, 2005; WHO, 2003; O’Brien, Petrie & 
Raeburm, 1992). The word adherence is preferred by many healthcare providers because 
compliance suggests that a patient is passively following the doctor’s orders and that the 
treatment plan is not based on the therapeutic alliance or contract between the patient and the 
physician (Osterberg & Blaschke, 2005). According to Schonnesson et al. (2006), adherence 
may be operationalized in different ways, namely:  
● Dose adherence, which refers to the number and proportion of doses taken;  
● Schedule adherence, which refers to adherence taken on time; and 
● Dietary adherence, which refers to dose taken correctly with food.  
To be able to achieve optimal results from ART, all of these dimensions are required.  
 
2.2.2 Non-adherence  
Non-adherence, according to Miller (1997), may take various forms, such as not taking the 
medications at all, taking medication at the wrong time, taking the wrong dose due to 
misunderstanding treatment directions or prematurely terminating the medication without 
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consulting the health provider. Non-adherence also includes not filling prescriptions, self-
adjusting the regimen to modulate side effects and toxicity, and incorrectly understanding the 
doctor’s instructions (Chesney, 2003).  
 
2.3 Measurement of adherence 
The commonly used methods to measure adherence include biological assays, pill counts, 
electronic monitoring/medication event monitoring system (MEMS), pharmacy records, self-
reporting and direct observed therapy (DOT) (Toussi et al., 2008). Authors agree measuring 
adherence to ART is complex and difficult in both clinical and research settings, the biggest 
challenge being that up to now there is no “global standard” or “golden standard” to measure 
adherence since the methods being used are considered to have advantages and disadvantages 
depending on the setting (Nachega, Mills & Schechter, 2010; Sodergard, 2006; Chesney, 
2000). The commonly used methods to measure adherence are discussed below.  
 
2.3.1 Biological assays 
This method is used to measure the concentration of a drug, tracer compounds or its 
metabolite in the blood or urine of a patient (Vik et al., 2004). With this method the serum 
concentration of the drug will probably reflect to regimens of the medications taken and sub-
therapeutic levels will probably reflect poor adherence or suboptimal dose strength. However 
this method is burdensome to the health care providers, expensive and is susceptible to 
distortion by the patient (Osterberg & Blaschke, 2005). 
2.3.2 Pill count 
With this method the health care providers (HCP) count the number of pills that remain in the 
patient’s medication bottles or vials each time the patient visits the health facility (McLean, 
2003; Grymonpre et al., 1998). Pill counting is considered to be the easiest method for 
calculating patient medication adherence, cost effective and favorable for use in resource 
limited settings. However, some studies indicate that the technique may underestimate 
adherence in older populations as patients can manipulate the left over tablets prior to a 
follow-up appointment in order to appear to be following the regimen, in addition this 
method provides no information on aspects of taking medications, such as drug holidays 
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(omission of medication for a certain period of time) and dose timing which may be 
important in determining clinical outcomes  (Vik et al., 2004; Osterberg & Blaschke, 2005). 
 
2.3.3 Electronic monitor/medication event monitoring system (MEMS)  
MEMS was developed by Aardex-Corporation and is used to assess the number of the 
missing pills during a period as well as adherence to a dose schedule (Bangsberg et al., 
2001). The system electronically monitors when the pill bottle is opened as a device is fitted 
on the pill container which records the date and time the medication container is opened. This 
device is considered to provide reliable measurements for adherence and a researcher can 
periodically download the information to a computer (Bangsberg et al., 2001). Each time the 
bottle is opened it is assumed that a dose is taken which however may lead to overestimation 
of adherence if the dose was not actually taken. The availability and the cost of this system 
could limit the feasibility of its use in resource limited settings (Moulding, 2007; Osterberg & 
Blaschke, 2005). 
 
2.3.4 Pharmacy records 
This method can be used primarily for medications that are taken for chronic illnesses, such 
as hypertension and patients on HAART. The strategy uses data provided by the pharmacy 
that indicate the dates on which ART were dispensed. Rougemont et al. (2009) highlight that 
pharmacy refill adherence is easily accessible and in low–income countries should be 
considered as an alternative to CD4 count monitoring for identification of patients at risk of 
virological failure. Concerns have been expressed regarding the completeness and reliability 
of these records (Vik et al., 2004). The pharmacy records are considered to provide only an 
indirect measure of drugs consumed, but the patterns of over and under consumption, for 
periods less than that between refills, cannot be assessed.  
 
2.3.5 Self-report 
Patients self-report is a relatively simple and efficient method of assessing adherence in 
clinical practice, it can be widely used in many resource limited settings. It requires patients 
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to report on their adherence behavior at each visit (Chesney et al., 2001). According to 
Bangsberg et al. (2001) and Moulding (2007) self-report is believed to be very flexible, cost 
effective, and can help to identify the reasons for poor adherence and consequently reduce 
defaulting 
 
Other tools used to collect information include: questionnaires; surveys; diaries; visual 
analogue scales (Chesney et al., 2001). With questionnaires, a patient is asked to answer the 
questions about his/her adherence behavior. A visual analogue on the other hand is an 
instrument that is used to measure the adherence behavior of a patient across a continuum of 
values (Chricton, 2001). However the self-report method is less sensitive when compared 
with other methods such as MEMS and unannounced pill counts; since questioning the 
patients can be susceptible to misrepresentation and result in overestimating the patient 
adherence (Chesney et al., 2001).  
 
2.3.6 Direct observed therapy 
This strategy requires that patients take their daily treatment under the direct supervision of a 
health-worker or a direct observed therapy (DOT) supporter, at the health centre or at the 
DOT point (WHO, 2003). This strategy has been successfully and extensively used in the 
management of tuberculosis (TB) but may not be suitable for lifelong treatments such as 
ART (Nachega et al., 2010). According to Sarna et al. (2005), DOT-ART was implemented 
to ensure that patients are consistent in their follow-up schedules. According to Nachega et 
al. (2010) a study done in rural Haiti showed that DOT-ART was acceptable and associated 
with good clinical outcomes. Based on a study conducted by Nachega et al. (2010) in Cape 
Town that evaluated partial DOT-ART by a nominated treatment supporter versus self-
administration, it was found that DOT did not confer a significant advantage in virology 
suppression or adherence. 
 
2.4 Factors that influence adherence in HIV treatment  
These factors can be categorized as religious, cultural, family and community factors; patient 
related factors; socio-economic factors; work place related factors; and health care team and 
system related factors. 
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2.4.1 Religious, cultural, family and community-related factors 
Religious beliefs 
In terms of religious/spiritual beliefs the literatures suggests that church attendance, religious 
practices and spiritual beliefs are believed to improve adherence. In population subgroups 
where religious practices play a pivotal role, religious beliefs can also play a negative role in 
treatment adherence due to stigma attached to HIV disease since it is associated with immoral 
behaviors and considered to be casually transmitted hence an HIV infected person is feared 
(Ware et al., 2009). According to UNAIDS (2009), AIDS stigma and discrimination are still 
common in Indian society, including the work place, which results in many infected people 
losing their jobs. It has been noted that HIV stigma may be a barrier to medication adherence. 
Stigmatization of an HIV infected person is caused by fear of death and disease, inadequate 
knowledge about HIV, sexual morals and lack or poor knowledge of stigma (Theron, 2005). 
If patients are seen by family members, neighbors, or friends, to be taking ART this is likely 
to convey a signal that they are HIV positive or living with AIDS. This leads to attempts to 
hide the medication or change dosing schedules which may affect adherence (Klitzman et al., 
2004). According to a cross-sectional study conducted in Botswana, 15% of the non-adherent 
patients feared to be stigmatized (Weiser et al., 2003). It was found that patients on ARTs 
defaulted or even missed their follow-up dates because they find it difficult to take their 
medication in the presence of others (Nachega et al., 2010). Therefore those infected fear to 
disclose their HIV status or to be seen at the clinic and eventually default treatment (Nyblade 
et al., 2003; Kelly, 2001). 
 
Conceptualization of health and illness in a traditional African context may be considered a 
supernatural phenomenon linked to a supreme deity, ancestral spirits, and other objects (Kale, 
1995). Traditional healers, according to Kale (1995), play a role in determining a patient’s 
health status and either reduce or enhance his or her well-being. There is a possibility that 
such medical seeking patterns might affect adherence (Walker, Reid & Cornell, 2004). 
 
Cultural beliefs  
A study conducted in Tanzania found that beliefs that people are bewitched played a role in 
contributing to poor adherence to treatment (WHO, 2006). Patients’ beliefs and 
understanding about their illness and the effectiveness of treatment they are taking are 
predictive of adherence. 
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Furthermore social circumstances of people might play a role in adherence. According to 
Swartz (1995) there are cultural and contextual factors unique to South Africa that may affect 
adherence and ART uptake in the context of the national roll-out. According to Edginton, 
Sekatan and Goldstein (2002), an ethnographic study conducted in South Africa noted that 
some patients stopped taking their ART medications after consulting a traditional healer 
because they were told that their problems require traditional medications only. Similarly, 
some patients were told by traditional healers that they are healed and therefore did not need 
to take the medications anymore (Khan et al., 2005). South Africa is estimated to have 
between 150,000 and 200,000 practicing traditional healers (Kale, 1995). According to 
Abdool Karim et al. (1994) 80% of the South African population consults traditional healers. 
Traditional healers usually attend to many patients’ needs in South Africa, Namibia, and 
many other African countries. 
 
Family and social support 
Lack of family and social support impact negatively on adherence. Social support for 
adherence includes encouragement from friends and family for a patient to co-operate with 
the recommendation and prescription of the health professional (DiMatteo, 2004). It is 
reported that difficult family circumstances such as those noted in South Africa  contributed 
to high rates of migration, teenage pregnancy, overcrowded living conditions, family 
violence, and substance abuse, and are likely to create conditions under which family and 
social support are poor, contributing to compromised adherence rates (Wood, Tobias & 
McCree, 2004). HIV patients living alone were reported to not be taking their medications 
because there was no one to take care of them at home (Jaiswal et al., 2003). 
According to Maskew (2007), some people do not disclose their HIV status to relatives and 
friends because they fear discrimination should their status be known. People with such fears 
find it difficult to take their medications in the potential presence of relatives’ friends and 
work colleagues and consequently miss their doses.  
 
2.4.2. Patient factors 
Factors that influence patients’ willingness to adhere to treatment include: poor 
knowledge/understanding and beliefs about medications effectiveness, forgetfulness, alcohol 
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intake, lack of commitment, non-disclosure, unplanned travelling, lower education level, 
depression and severe anxiety. 
 
 Poor knowledge/understanding and beliefs about medications effectiveness 
If a patient is well informed about HIV and believes that HAART is effective and prolongs 
life, and knows that poor adherence may lead to viral resistance and treatment failure, this 
contributes to a patient’s ability to adhere (Gifford et al., 2000). Studies conducted in 
Tanzania on adherence for other diseases indicated that patients often do not have enough 
knowledge or do not remember how to use various prescribed medicines, contributing to their 
irrational use (WHO, 2006). According to a study conducted by Osterberg and Blaschke 
(2005), 9% of patients in Ruanda reported not taking medications because of lack of 
information.  
 
 Forgetfulness 
Personal factors such as forgetfulness are predictors of sub-optimal adherence. A study done 
in Ruanda found that forgetfulness was among the top three reasons for missing a dose 
accounting for 30%, furthermore it was found that 44% of patients who took the correct 
number of doses but not according to schedule stated this was due to forgetfulness (Osterberg 
& Blaschke 2005; Baptiste, 2008). According to a study conducted by the Adult AIDS 
Clinical Trial Group in USA amongst  all patients taking combination antiretroviral therapy 
the most common reason for missing medications given by 66% of patients was forgetting to 
do so (Chesney, 2000). 
 
 Alcohol intake 
More recent studies indicate that alcohol intake is the most frequent and important factor 
reported to negatively impact adherence in developing countries (Pulvirenti, 2005; Gifford et 
al., 2000; Nachega et al., 2010; Chesney, 2000). Studies conducted in India, Tashkent, 
Uzbekistan, Mexico, and South Africa, found excessive alcohol intake contributed to 
treatment defaulting (Guillen et al., 2008; Allen, 2006; Hasker et al., 2008; Jaiswal et al., 
2003). The studies found that patients tent to forget or ignore taking their medication after 
excessive consumption of alcohol (Guillen et al., 2008; Jaiswal et al., 2003; Allen, 2006). 
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 Lack of commitment 
The patient’s degree of commitment to follow a treatment regimen and, the degree of 
confidence in being able to follow it, influence treatment adherence (WHO, 2003). Having a 
constant goal will influence the effort used to bring a course of behavior to a successful 
conclusion and is likely to increase with perceived behavior control. For instance if two 
individuals are equally strongly motivated to learn a skill and both try to do so, the person 
who is confident that he can master this activity is more likely to perceive success compared 
to the person who doubts his ability (Ajzen, 1991). 
As a general rule, strong intentions to perform a behavior lead to a more likelihood of the 
behavior being performed. Therefore if a patient on HAART is strongly motivated to adhere 
to the treatment such a patient will be adherent but on the other hand if the patient believes 
that discontinuing the medication is the right thing to do and if the social network is weak 
then the patient will eventually default (Bandura, 1994). It is therefore necessary health 
workers to continuously educate and emphasize the importance of adherence to be able to 
strengthen patients’ confidence and to build self-management skills. 
 
 Unplanned traveling 
According to WHO (2007), patients find it difficult to adhere to their treatment schedules 
when they are away from home and in the presence of strangers. A study conducted in the 
USA by the adults AIDS clinical group indicates that 57% of those who missed their doses 
claimed to have been away from home (Chesney, 2000). This happens most of the times 
when patients travel to social events that last for several days such as weddings, funerals or 
any other family related gathering. According to Munro et al. (2007) it was found that 
patients find it difficult to continue taking their treatment in the presence of others or miss 
their follow-up dates and consequently default treatment. 
 
 Lower education level  
Some studies indicated that patient who is illiterate have poor knowledge related to diseases, 
self-management, and the worse self-reported treatment leading to poor treatment adherence 
and in turn leading to a 30% to 50%  increase odds of hospitalization and high annual health 
care cost (Powell & Kripalani, 2005; Maskew et al., 2007; Bassetti et al., 1999). Bosworth 
and Oddone (2002) specify the importance of basic reading skills in a health care setting 
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where patients participate in the planning and implementing therapeutic regimen. According 
to them in the USA it was found that only 42% of the patients in two public hospitals were 
able to understand instructions for taking medications on an empty stomach and 26% were 
not able to understand that a next appointment was scheduled. A study conducted in Nepal, 
amongst non-adherent patients, indicates that the majority of the participants did not have 
basic levels of literacy and they indicated that they did not understand what was said by the 
health-workers which resulted in patients defaulting treatment (Wares et al., 2003). 
 
 Depression and anxiety  
According to the WHO (2006), psychological factors such as depression and anxiety are 
predictors of sub-optimal adherence and most people with HIV usually suffer from a 
psychiatric disorder. It is reported that up to 70% of AIDS patients have symptomatic 
depression and/or anxiety. Moreover it is indicated that patients who are on long term 
treatment for diseases such as hypertension, TB, diabetic, and HIV/AIDS, tend to suffer from 
depression and stress as they are obliged to take medications on a daily basis (Simpson, 2006; 
Kim et al., 2003). Studies indicate that mental conditions, such as anxiety, stress and 
depressive disorders, have a negative effect on treatment adherence (Kagee & Le Roux, 
2007; Kilbourne et al., 2005). 
 
2.4.3 Health system factors 
Health system factors such as long distances to health facilities, shortage of staff at clinics, 
poor patient provider relationship and health-workers’ attitudes have been identified as 
barriers to adherence to ART (Charurat et al., 2010; WHO, 2003; UNAIDS, 2010). 
 
 Long distances to health facilities 
Long distances to health facilities impact on adherence. Despite the fact that adherence is said 
to be 90% amongst people taking ART in Sub-Saharan and Africa, transportation over long 
distances from/ to health facilities remains an important barrier to sustain adherence to 
medications (Charurat et al., 2010; Rougemont et al., 2009; Ware et al., 2009; Bennet et al., 
2008). A study done in Addis Ababa found that it took up to two hours for  patients to walk 
to their the nearest health facility to receive treatment (Demisse, Lindtjorn & Berhane, 2002). 
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Transportation difficulties, according to Mills et al. (2006), were often the major interference 
to adherence.   
 
 Shortage of staff at clinics 
 
Factors that influence adherence to therapy include overworked health providers, because of 
overcrowding at the health facilities, which in turn lead to patients leaving the clinic without 
medications contributing to non-adherence (WHO, 2003). According to UNAIDS (2010), 
most Sub-Saharan Africa countries, as well as countries in Asia, the Middle East, and North 
Africa, are overburdened by a shortage of health-workers which in turn leads to 
overcrowding at health facilities. 
According to Mapunjo and Urasa (2007), developing countries are faced with many 
challenges such as shortage of qualified human resources leading to lack of knowledge on 
adherence and of effective interventions for adherence. In a study conducted in Tanzania it 
was found that one third of the health facilities did not have a social worker.  
 
 Poor patient – health provider relationship 
A large number of studies indicate that poor follow-up by providers, and ill-treatment by 
providers, such as scolding the patient for missing appointments and refusing to give more 
medications, contributed to non-adherence among patients (WHO, 2003; Munro et al., 2007a; 
Hasker et al., 2010). Non-compliance, according to Snelgrove (2006), can damage the 
relationship between health professionals and patients. Good relationship between doctors 
and patients is an aspect of social support that leads to good adherence (Ciechanowski et al., 
2001). According to Mills et al. (2006), 17 studies reported that a trusting relationship with 
HCPs was a facilitator of adherence. A health-worker is most of the times seen as a person in 
authority, in possession of specific expertise, and in whom a patient invests hope for the 
recovery process (Bary, 2004).  
 
2.4.4 Unplanned ART interruptions 
There are various types of different crisis that can potentially undermine ART treatment. 
According to Veenstra et al. (2010) in Southern Africa and broader region, the 2008 floods in 
Mozambique, the ongoing political and economic crisis in Zimbabwe and the 2007 public 
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sector strike in South Africa lead to poor access to food supplies and poor access to health 
care resulting in inadequate management of both acute and chronic diseases and those on 
ART not being able to access the medication they require.  
According to the WHO (2003) changing environmental situations such as natural disasters 
are some of the factors reported to have a significant negative effect on adherence. 
Unfavorable contexts limit individual’s control over their own treatment, in Zimbabwe 
according to Veenstra et al. (2010) there were reports of patients on ART missing drug doses, 
sharing drugs, selling their drugs and changing regimens to try and cope with inadequate drug 
supplies and poor economic circumstances so increasing concerns of a drug resistant HIV 
epidemic. 
2.4.5 Socio-economic factors  
The socio-economic status of a patient has been indicated to impact on adherence of ART 
treatment. Factors such as unemployment and poverty have been found to have an influence 
on ART adherence. A study, conducted at the Temba Lethu Clinic at Helen Joseph Hospital 
in Johannesburg, as well as a cross-sectional study conducted in Botswana of the social, 
cultural and structural determinants of treatment adherence, shows that financial problems are 
the leading cause of failure to follow-ups since these represents 34% and 44% of all the 
problems. Patients who defaulted ART cited transport cost and having to pay to open a file at 
each visit as the biggest obstacle to obtain treatment (Maskew, MacPhail, Menezes & Rubel, 
2007; Weiser et al., 2003). Poverty in itself is likely to affect adherence, for example, funds 
to travel to an ART clinic may not be available and food required to be taken with 
medications may not be easily affordable. The demands of several competing responsibilities, 
such as work and family life, together with the stress associated with poverty and 
unemployment may preclude an acknowledgement of the importance of complying (Mills et 
al., 2006; Simoni et al., 2002). However poverty is also an environmental and political 
problem in the sense that appropriate transport infrastructure may not exist in rural areas and 
in many townships. The need to take time off work without pay and transport problems to 
attend clinic appointments were serious barriers to adherence among patients with 
hypertension and diabetes, to the extent that many failed to arrive for appointments or fill 
prescriptions (Kagee et al., 2007).   
 
2.4.6 Work place factors 
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Studies have indicated that some patients have prioritized work over treatment since some 
patients hide their diseases for fear that their employers may discover their disease and 
perhaps terminate their employment with consequent effects on adherence (Maskew, 
MacPhail, Menezes & Rubel, 2007). Reports also indicate that for many patients they have to 
choose between work and adherence (Maskew MacPhail, Menezes & Rubel, 2007). In rural 
areas, for example, there is a conflict between attending a clinic for treatment and the need to 
earn some money for a living. Such patients have no option but to abandon their treatment as 
it is too difficult to combine the two.  
  
2.4.7 Treatment related factors 
Side-effects and treatment fatigue are believed to have a significant impact on ART 
adherence (Kaona et al., 2004; Wares et al., 2003). 
 
 Side-effects 
According to Snelgrove (2006), compliance can also be problematic when patients are 
expected to continue to take medication unquestioningly even though it is causes adverse 
side-effects. Side-effects of medications were found to contribute to 9% of the reasons 
leading to non-adherence among patients in Botswana (Weiser et al., 2003; Gaskins, 2000). 
According to a study conducted in Pakistan amongst TB treatment defaulters they cited that 
they defaulted because they were not provided with adequate information regarding treatment 
side-effects (Khan et al., 2005).  
 
 Treatment fatigue 
Some studies cited patients on ARVs being tired of taking them and often desired to take a 
holiday because the drugs were not being well tolerated by their bodies (WHO, 2006). 
According to a cross-sectional survey conducted among the physicians of a Swiss HIV cohort 
study amongst the most common reason for patient discontinuing treatment was the 
perception that treatment was too complicated (18%) leading to treatment fatigue (Bassetti et 
al., 1999).  Conferring to Eholie et al. (2007) longer duration of treatment regimens in some 
studies were reported to be associated with treatment fatigue and exhaustion as the patients 
concerns regarding the lifelong drug dependency and consequences. 
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2.5 Theories of health behavior  
Adherence remains a major problem in the clinical settings of chronic conditions treatment. 
According to Sodergard (2006), although adherence has been thoroughly examined still there 
is no definite solution regarding low adherence. This section presents the theories used to 
explain the models that can be used to explain treatment defaulting behavior namely: Ley’s 
model of communication, and the theory of planned behavior (TPB). 
2.5.1 Ley’s model of compliance  
Treatment adherence can be explained theoretically using Ley’s model of compliance since it 
attempts to describe the interaction between factors that lead to adherence (Olivera, 2009; 
Ogden, 2000). This theory claims that compliance can be predicted by a combination of 
patient satisfaction with the consultation with the HCPs and the importance of memory 
pertaining to , for example, understanding of information, as well as the ability of a patient 
being able  to recall the information provided by the HCPs (Olivera, 2009; Kessels, 2003, 
Ogden, 2000). 
 
Patient satisfaction 
Patient satisfaction, according to this model, is determined by the content of the consultation. 
Studies show that patient satisfaction depends on various components of consultation 
especially the emotional support that a patient receives from health care givers (Munro et al., 
2007b). According to Olivera (2009), patients want to know as much information as possible, 
even if this information is bad news. Therefore it is important for HCPs to provide adequate 
information to their clients regarding the diagnosis and prognosis of the disease and the 
prescribed treatment as well as the potential side-effects of the treatment as this is believed to 
reduce defaulting behaviors (Ogden, 2000). 
 
Patient understanding 
Patient understanding of information means that patients will only be able to effectively 
adhere to the given instructions when provided with a clear understanding of what is expected 
of them or with respect to their prescribed treatment (Munro et al., 2007b). According to 
Kessels (2003), the greater the amount of information presented, the lower the proportion 
correctly recalled; furthermore almost half of the information that is remembered is incorrect. 
Lack of provision of information by HCPs may lead to defaulting due to a lack understanding 
by patients. Therefore it is vital that HCPs clearly clarify the instructions that they are 
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providing to patients on HAART as well as TB patients to curb defaulting behaviors (Ogden, 
2000). 
 
Patient recall 
Patient recall according to Ogden (2000) is the extent to which the patients are able to 
remember the information provided by HCPs. This theory stresses the importance of memory 
next to factors such as underlying information and satisfaction with treatment. According 
Kessels (2003), 40-80% of medical information provided by health-care practitioners is 
forgotten immediately. The same author argues that patients tend to recall the information 
that was clearly explained to them by the HCPs which consequently reduces defaulting 
behaviors. The greater the amount of information presented the lower the proportion correctly 
recalled (Kessels, 2003). Various factors have however been found to influence the ability to 
recall the information provided. These factors include the education level of the patient, 
medical knowledge, and mental instability such as anxiety (Munro et al., 2007b; Kessels 
2003; Ogden, 2000). 
 
2.5.2 Theory of planned behavior (TPB) 
The Theory of Planed Behaviors explains the link between attitudes and behaviors; it as well 
predicts behaviors based on the understanding that behavior can be planned (Armitage & 
Conner, 2001). According to Armitage and Conner (2001) this theory can help health care 
providers to understand how they can change the behavior of their patient. 
The central factor in the theory being that of an individual’s intentions to perform a given 
behavior and such intentions are assumed to indicate the motivational factors that influence a 
behavior. On the other hand the person might be motivated to perform a behavior but the 
performance depends to some degree on non-motivational factors, such as, availability of 
required opportunities, and resources, such as, time, money, skills and co-operation of others 
(Ajzen, 1991). A patient may be willing to adhere but because of lack of resources will 
default treatment. Therefore the resources together with the opportunities available to a 
person must to some extent dictate the likelihood of behavioral achievement.  
 
According to Ajzen (1991) in TPB there are three conceptually independent determinants of 
intention which are considered vital in guiding human behavior and are presented below: 
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i. Attitude towards a behavior which refers to the degree to which a person has a 
favorable or unfavorable evaluation or appraisal the behavior in question. 
ii. Subjective norms are a social factor predictor which refers to the social pressure to 
perform or not perform the behavior.  
iii. Control is an antecedent of intention which refers to the perceived ease or difficulty of 
performing the behavior and is assumed to reflect past experiences as well as 
anticipated impediments and obstacles. 
The above theory (TPB) can be applied to improving or developing health communication 
interventions for patients on HAART. The health care providers can develop behavioral 
therapy for HIV patients using this theory.  
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CHAPTER 3: METHODOLOGY 
 
3.1 Introduction 
This chapter discusses the methodology used in this study, which includes aims and 
objectives, the study design, the study setting, research population, sample and sampling 
procedure, data collection and analysis, ethical considerations and study limitations. 
 
3.2 Aim and objectives 
The study explored factors that influence adherence to ART amongst patients at Oshakati 
Intermediate Hospital, Namibia. 
The specific objectives of the study were:  
● To describe experiences of patients being on ART and living with HIV/AIDS, 
● To explore the challenges of patients’ socio-economic status/position had on 
adherence, 
● To explore the of role that health care services delivery played on adherence,  
● To explore community-related stigma and discrimination and its influence on patient 
adherence, 
● To explore factors related to treatment regimen that influenced adherence behavior. 
 
3.3 Study design 
Research design refers to the plan and overall structure of an investigation used to obtain 
evidence to answer research questions. Parahoo (1997: 142) defines a research design as “a 
plan that describes how, when and where data are to be collected and analyzed”, while 
Burns and Grove (2003: 195) describe it as “a blueprint for conducting a study with 
maximum control over factors that may interfere with the validity of the findings”. This study 
is qualitative, explorative and descriptive in nature. The rationale for using the qualitative 
approach was to meet its aim to describe the patients’ experiences of being on ART and to 
explore the factors that influence adherence to ART. Pope, Ziebland and Mays (2000) 
consider qualitative research designs to be suitable for research that aims to explore health 
behaviors because qualitative studies place more emphasis on the lived experience of 
participants in an attempt to understand the phenomenon in its entirety rather than focusing 
on specific concepts. An exploratory study design enables greater openness from participants 
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and allows greater flexibility in data collection by giving participants room to give more 
information. This is confirmed by Baum (2008:180) who say that: “qualitative research is 
best suited for studies that aim at exploring health behaviors and gives understanding of how 
people interpret health and diseases and make sense of their experiences as well as a 
systematic review of the research question that cannot be answered by quantitative methods”. 
During the current study, open-ended questions and probes were used to explore more in-
depth information form the participants. This allowed the participants to express themselves 
in their own words which would have been difficult if using quantitative methods. 
3.4 Description of the study setting  
The study was conducted at the Communicable Disease Clinic (CDC) at the Intermediate 
Hospital Oshakati (IHO) which is situated in the Oshakati district. Oshakati district consists 
of poor rural communities situated at the outskirts of the suburbs of Oshakati town. There are 
high levels of poverty and low levels of education among people living in these communities. 
The IHO is a 750-bed hospital which serves the Oshakati district. Apart from the IHO the 
district has five health centers, 11 clinics and one private hospital. Recently the provision of 
ART services was delegated to the IHO CDC and the cumulative number of persons enrolled 
in the HIV care at this facility is 13,561. The ART services recently were delegated to two 
health centers. The IHO CDC was chosen for this study because it is the main clinic in the 
district that caters for the biggest number of patient from different areas and different 
backgrounds.  
 
At the IHO, adherence to ART is determined by balancing the quantities of pills when the 
extras exceed a week supply. In view of this an allowance of two days is given to each patient 
outside the prescribed date of visit. If a patient misses the first month follow-up appointment  
but eventually presents within the allowance period  then such a patient is considered to have 
missed his/her appointment date but adherent to treatment if the issued  medications balance. 
 
3.5 Study population 
According to Parahoo (1997: 218), population refers to “the total number of units from which 
data can be collected”, such as individuals, artifacts, events or organizations. Conferring to 
Burns and Grove (2003) population is all elements that meet the criteria for inclusion in a 
study. In this study the study population included all adult males and females aged 18 years 
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or older who were on ART at the selected health facility, and who were identified as poor 
adherents by the health-care team.  
 
3.6 Sampling  
Polit and Hungler (2003: 234) define a sample as “a representative portion of the population 
under study”. Sampling is a process by which the sample is selected so that research findings 
can be generalized to the population. According to Bassett (2001), qualitative research does 
not require a large random sample because qualitative studies seek to describe a range of 
experiences rather than collect numbers for statistical analysis. In qualitative research the 
sample size depends on the purpose of inquiry. Therefore the situations, persons and events 
most likely to yield information-rich data about the problems are selectively chosen 
(Holloway & Wheeler, 1997). This type of sampling is known as purposive sampling and in 
some instances sampling might continue until data saturation has been achieved. 
 
After an explanation of the purpose of the study, the nurse together with the community 
counselor those that are operating at the CDC both helped to identify potential participants 
from the ART register who were considered to be poor adherents. Patients attending the CDC 
for follow-up and who met the eligible criteria were selected. Sampling was done based on 
the following criteria, namely clients who were:  
 identified as poor adherents to ART by the clinical team;  
 residents of Oshana region;  
 able to communicate in Oshiwambo, Afrikaans, Portuguese or English. (These 
languages were chosen because they are the most common spoken ones in the area 
where the study was conducted.)  
The nurse together with the community counselor informed the researcher of the date when 
potential participants were coming for their appointments and provided the contact details of 
the identified defaulters. During the period 17 January 2010 to 16 February 2010 potential 
participants were approached by the researcher for possible participation in the study. The 
researcher then met the eligible participants in March 2010 and explained the purpose of the 
study (Appendices 1 and 3). Each participant agreed on the date of interviews and was asked 
to give written consent to agree to participate in the study (Appendix 4). The eligibility 
criteria were: adults aged 18 and above; they had to be residents of the Oshana region; 
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identified as poor adherents to ART and speaking Oshiwambo, Afrikaans, Portuguese or 
English A total of 12 participants were interviewed. The participants comprised equal 
numbers of employed/unemployed, males/females and those co-infected with TB or other co-
morbidity. Participants were chosen to represent, as far as possible, a wide range of 
experiences and perspectives of ART patients at the IHO CDC.  
 
3.7 Description of participants 
Key informants comprised staff at the CDC: a clinician, a registered nurse, a pharmacist 
assistant and a community counselor. In-depth interviews were conducted with the 12 
participants and their characteristics are presented in Table 1 below. As evident in the table 
participants were between 27-60 years old and the majority of them were not married. There 
were more unemployed females compared to the males. 
 
. 
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Table 1 Characteristics of the Participants 
Characteristic Female Male Total 
Age 
27-30 
31-40 
40-45 
46+ 
 
2 
3 
1 
- 
 
- 
4 
1 
1 
 
2 
7 
2 
1 
Started treatment  
2006 
2007 
2008 
2009 
 
1 
1 
1 
3 
 
- 
- 
2 
4 
 
1 
1 
3 
7 
Marital Status 
Single 
Married 
Co- habiting  
Widowed 
 
5 
1 
- 
- 
 
3 
2 
1 
- 
 
8 
3 
1 
- 
Employment Status 
Employed  
Unemployed 
 
3 
3 
 
3 
3 
 
6 
6 
Co- infected 
Not- Co-infected 
Co-infected with TB 
Co- infected MDR 
Co –infected with 
other diseases 
 
3 
2 
- 
1 
 
3 
2 
1 
- 
 
6 
4 
1 
1 
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3.8 Data collection 
According to Burns and Groove (2005) data collection is the precise and systematic gathering 
of information relevant to a research problem using instruments which can be in the form of 
questionnaires, interview schedules and guides, field notes and records and/or artifacts. In a 
qualitative study the most common data collection methods used are interviews, observation, 
and examination of written texts, field notes and artifacts.  
 
In this study two different data collection methods were used, namely key informant 
interviews (Appendix 2) and in-depth interviews (Appendix 1). Prior to conducting in-depth 
interviews with the 12 participants the researcher conducted focused interviews with the key 
informants at the selected study site. The researcher asked the participating clinician, 
registered nurse, pharmacist assistant, and a community counselor, to give their personal 
respective views on the problem of adherence and causes for poor adherence. Bowling (2002) 
considers in-depth interviews as a good tool to use when seeking to learn about people’s 
feelings, thoughts and experiences. In this study in-depth interviews were the primary source 
of data collection. Interviews in this study were conducted in languages of each participant’s 
choice, mainly Oshiwambo, English, Africans or Portuguese as the researcher is conversant 
with all these languages spoken in the region. 
 
3.9 Data analysis 
Data analysis is the interpretation and organization of data collected during fieldwork for the 
purpose of discovering important dimensions and patterns of relationships (Polit, Deck & 
Hungler, 2001). According to Henning, Van Ransburg and Smit (2004), in qualitative 
research data analysis is an on-going, emerging and interactive non-linear process. Similarly, 
in this study data analysis continued simultaneously with data collection. 
 
In-depth interviews with the participants and key informants were taped and transcribed 
verbatim to ensure that no information was lost prior to starting data analysis. In this study 
data analysis commenced as soon as the taped interviews were transcribed and the data were 
read though over and over to identify emerging themes, categories and sub-categories. 
Qualitative data analysis according to Coffey and Atkinson (1996), needs to be conducted 
with rigour and care. Phenomenological research analysis starts as soon as the first data are 
collected. Prior to data analysis a researcher has to clarify personal preconceptions about the 
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phenomenon under study. This is known as ’bracketing’ suspending the researcher’s meaning 
and interpretations as much as possible and entering into the world of the individual 
interviewed (Tesch, 1990). In this study bracketing and reflexivity were applied during data 
analysis.  
The transcribed interviews were coded into main themes and sub-themes and notes were 
taken throughout the interviews to capture non-verbal information. Thematic analysis method 
was used for data analysis, following the five stages of thematic analysis as described by 
Pope, Ziebland and May (2000), namely familiarization, identification of a thematic 
framework, indexing, charting, and mapping and interpretation. After the completion of the 
tape-recorded interviews, the researcher replayed the tape and listened carefully to the 
content as well as the questions asked. The tape-recorded responses during the face-to face 
interviews were manually transcribed verbatim and read over and over to gain a sense of the 
whole.  
 
3.10 Rigour 
When conducting qualitative research rigour is of utmost importance to ensure that results 
and interpretations are credible and trustworthy and the basic approach to ensure rigour is 
systematic and self-conscious research design, data collection, interpretation and 
communication (Mays & Pope, 2000). According to Marshall and Rossman (1995), 
credibility is a process of demonstrating that an inquiry is conducted in a manner that ensures 
the accuracy of how subjects were identified and described. The researcher in this study is a 
Namibian registered nurse and midwife employed by the Namibian Ministry of Health and 
Social Services. The researcher works at the IHO as the chief registered nurse (supervisor) of 
the outpatient department casualty service area and CDC where the study was conducted. 
Based on this it is evident that the researcher’s possesses knowledge to conduct research of 
such a sensitive nature. The researcher was able to gain access to ART patients as well as 
address concerns about confidentiality amongst participants. To ensure credibility, the 
researcher used the triangulation method (Gifford, 1996), whereby the information from the 
in-depth interviews was triangulated with the information from key informants. 
 
The researcher strictly adhered to the selection criteria and only eligible participants were 
interviewed to ensure credibility. An uniform interview guide was developed and used with 
every participant. With the help of an experienced independent transcriber the interviews 
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were transcribed verbatim to ensure that no data were lost in the process. The transcribed 
interviews were sent to the researcher’s academic supervisor for inputs on the quality of 
interviews conducted and the coding of data was presented as well in order for the supervisor 
to verify perspicuity. 
3.11 Ethical considerations 
Ethical approval for the study was obtained from the University of the Western Cape (UWC) 
Senate Research Committee. Permission to conduct the study was sought from the Permanent 
Secretary of the MOHSS. The letter of approval was sent the regional director of the Oshana 
Region, the medical superintendent of IHO and to the hospital management as well as to the 
doctor in charge of the CDC (Appendices 5 and 6). 
 
The purpose of the study was explained to the key informants as well as the participants and 
then written consent (Appendix 4) was obtained from those who were willing to participate 
prior to the interview. The purpose of the informed consent was to ensure that the participants 
understood what was expected of them and that they agreed to take part (Terblanche, 
Durkheim & Painter, 2007). 
 
Participating in the study was voluntary for both groups (12 participants and the key 
informants) and they were assured of anonymity. The researcher made sure that all aspects of 
the study were handled in a way which was respectful to the human rights and needs of the 
participants (Human Sciences Research Council, 2009). Participants were assured that data 
would be treated in a confidential manner and they were informed about their right to 
withdraw at any time during the study without any consequences. They were also assured that 
refusing to participate in the study would not affect future treatment at the clinic. They were 
assured that the information gathered would only be used for research purposes for this study. 
An information sheet was provided to all participants and key informants. They were 
informed that the researcher intended audio taping the interviews prior to commencement of 
the interviews which were conducted in a private room available at IHO to ensure privacy of 
the participants. To ensure anonymity, personal details of the participants were not recorded 
and all data have been kept secure. Data were captured personally by the researcher on a 
personal computer thus the researcher has sole access to these data.  
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CHAPTER 4: RESULTS 
Main themes 
The research analysis of the interviews is clustered around the following six themes: 
 Social factors 
 Patient related factors 
 Health service factors 
 Socio-economic factors  
 Work place related factors 
 Treatment related factors 
The data of the results are presented in Table 2. Presentation of participants’ comments is in 
italics. 
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Table 2: Classification of Results 
THEMES SUB-THEMES CODES 
1. Social factors 1.1 Spiritual beliefs ♦Faith in healing 
♦Traditional therapies 
1.2 Stigma  ♦Emotional disturbance 
♦Non-disclosure of HIV status 
♦Unwillingness to take Antiretroviral Treatment in the presence of others 
♦Patients accessing treatment at clinics far from home. 
♦Lack of social support 
1.3 Discrimination ♦ Emotional abuse 
♦Depression  
♦Isolation 
♦ Rejection by partner 
♦Lack of family support 
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2. Patient related factors  
 
2.1 Poor understanding of treatment regimen 
 
♦Awareness of the importance of adherence 
♦Knowledge of consequences of poor adherence 
♦Leftover pills 
2.2 Forgetfulness 
 
♦ Reminder of drug intake 
2.3 Alcohol use 
 
♦Difficulties to stop using alcohol 
♦Lack of memory 
♦ Exposure 
2.4 Lack of commitment ♦Networking 
♦ Peer group influence 
♦Lack of self-motivation 
2.5 Traveling ♦Unplanned traveling  
2.6 Lower education level 
 
♦ Poor understanding 
 
3. Health service factors 3.1 Long distance to health facility  ♦Transport cost 
3.2 Shortage of staff at clinics ♦Lack of order 
♦ Long waiting times 
3.3 Poor patient- health provider relationship 
 
 
♦Lack of empathy 
♦Lack of trust 
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4. Socio economic factors 4.1 Unemployment 
 
 
4.2 Unavailability of transport 
 
♦ Work-related migration 
 
 
♦ Inability to go for follow-ups 
4.3 Floods ♦ Inaccessible to health facility 
5. Work place related factors 5.1 Work related pressure 
 
5.2 Lack of support from employers 
♦ Losing jobs 
♦Encouragement 
 
6. Treatment related factors 6.1 Adverse Drug Reaction ♦ Side-effects 
6.2 Treatment fatigue  ♦Pill burden 
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4.1 Social factors 
In this study, social factors such as spiritual beliefs, stigma and discrimination, were reported to 
have had negative effects on participants’ adherence to medication and compliance with the 
health regimen. 
 
4.1.1 Spiritual beliefs 
Religious and cultural beliefs such as having faith in healing and reliance on traditional therapies 
had detrimental effects on adherence.  
 
♦Faith in healing 
Some participants reported that when they sought advice from friends, they advised them to rely 
on their faith instead of the medical or health care system. Participants, who turned to religion (a 
church) for support, were often advised by fellow church members to rely on God only. This led 
to some of them defaulting on their treatment in solidarity to the faith. 
 
 “…when I told my friend that I was HIV positive he advised me that the best is to go to church 
for prayers and not to the hospital…” (Employed Male 36yrs). 
 
“…I joined this church for prayers and the church members told me that what I need is only to 
have faith in God. I don‟t need the pills. Therefore, I stopped them [the medication]. I only 
restarted the medication when I started not feeling well.” (Unemployed female 28yrs) 
 
“….Most churches are misleading they are telling people to stop taking their treatment so that 
they can pray for them to get healed….” (Nurse key informants (NKI) 
 
♦ Traditional therapies 
Patients with strong cultural beliefs first seek traditional healers’ opinions before consulting 
health-workers. The traditional healers, in turn, convince them that they are bewitched and can 
only be cured with traditional medications.  
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“…when I told my mother about my sickness I did not tell her I was HIV positive. Therefore, she 
took me to the traditional healers…One should not make a mistake to mix traditional medicine 
with these medications (ARVs); you will die. Therefore, I stopped taking these medicines to go 
and find out what was wrong with me from the traditional healer….” (Employed male 36yrs) 
 
“…most of my relatives don‟t know how to read and write just like me. When I became sick, they 
took me to the traditional healers…” (Employed female 37yrs, co- infected with TB) 
 
 “Hmm! …..even if some people tested HIV positive, they still believe in some other things like 
that they are bewitched and they rather seek help from traditional healers”.(Doctor key 
informants(DKI) 
 
4.1.2 Stigma  
Stigma in the community and from family members has impaired adherence to treatment since 
this causes affected persons to experience negative emotions, fear of disclosing HIV status and 
unwillingness to take ART in the presence of others. Furthermore, key-informants reported that 
patients have difficulties to get hold of treatment supporters to accompany them to the clinic 
since those close to them refuse, fearing to be seen at the clinic by people known to them, who 
might think that they are also infected with HIV. 
 
♦Emotional disturbance 
Some patients reported being depressed and unhappy because people from their location were 
gossiping about their HIV status. One participant claims to have reported those gossiping about 
his HIV status to traditional authorities, which resulted in those involved being referred to 
traditional courts. 
 
“…Last month I attended a traditional court about some ladies from our location that were 
spreading rumors as to who is HIV positive in our location…we had to report it because they 
made us feel very bad.” (Employed male 36yrs co-infected with TB) 
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 “…Community people should be left like that. Anyway nobody will stop them from gossiping 
about us who are HIV positive, and you know what? They enjoy when others are suffering…It 
really hurts a lot, sometimes I spend sleepless nights because of that.” (Unemployed female 
40+yrs co- infected with TB) 
 
“…my relatives, when they found out that I was HIV positive they were refusing to eat my food 
and they were telling their children not to eat or touch my food…it made me feel very sad.”(Self-
employed female 36yrs) 
 
♦Non-disclosure of HIV status 
Fears of stigmatization led to some participants selecting who to disclose their HIV status to. 
Patients feared their HIV status would be known by people in the community therefore they kept 
it a secret even from their partners. 
 
“...It is only I and my sister who know my HIV status; not even my girlfriends are aware. People 
in the community will laugh at you and makes your life impossible if they happen to know your 
HIV status.” (Employed male 36yrs) 
 
“…I was finding it very difficult to accept my HIV status; I also had a problem revealing it to 
anybody…. I later told my sisters, but that has also caused problems because I stared 
associating everything that has been said against me with my HIV status, even if it was not 
related to HIV ….” (Unemployed female 27yrs co-infected with other diseases) 
 
♦Unwillingness to take ART in the presence of others 
Participants reported that they would rather not take their treatment than take it in the presence of 
friends and acquaintances.  
 
 “…I get lots of visitors if they pay me a visit the time I was supposed to take my medications It 
becomes difficult for me to take them because they may suspect that I am on 
treatment…”(Employed female 37yrs, co-infected with TB). 
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♦ Patients accessing treatment at clinics far from home 
Stigmatization also led some participant to access medical treatment at clinics that are far from 
their homes to avoid being seen by people known to them when they go for follow-up 
appointments. 
 
 “…I come for treatment here because I did not want people in our area to know that I am on 
ARTs but now I am getting it difficult with transport money, I want to go back to the nearest 
clinic. (Unemployed female 28yrs). 
 
“Sister, here we get people from Omuthiya, which is more than a 100km from here. Leaving 
Omuthiya clinic behind, but what can we do? It is their rights Sister. Patients are afraid to be 
rejected by people in the community. (Community counselor key- informant (CCKY) 
 
“The clients, if they find people they know they just disappear without treatment, perhaps 
because they don‟t want people to find out that they are on treatment.” …Just look at those 
boxes they are very full of health passports of patients who just left the clinic without being 
attended to.” (NKI) 
 
♦ Lack of social support 
According to the key-informants, most patients experience difficulties in obtaining assistance 
from treatment supporters because the eligible ones refuse to come and accompany them to the 
clinic.  
 
“Most people find it difficulties to get treatment supporters because those that are close to them 
refuses to come with them to the clinic.”(CCKI) 
 
 “Yaa Sister, even those that are HIV negative are not willing to escort their relatives to this 
clinic because they fear to be seen coming here, people will suspect that they could be HIV 
positive.” (NKI) 
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4.1.3. Discrimination 
Discrimination in the community, as well as amongst family members, has contributed to 
impaired adherence due to emotional abuse, depression, isolation, rejection by partner as well as 
lack of family support. 
 
♦ Emotional abuse 
One of the participants complained that he was insulted by his wife’s relatives and accused of 
transmitting HIV to her.  
 
I was very annoyed when a school boy a relative to my wife insulted me and accused me of 
infecting my wife with the HIV….” (Employed male 36yrs). 
 
♦ Depression 
 The initial reaction to the HIV test result led to shock and depression, one participant reported 
that she almost committed suicide and another said that she wished to die because of being 
teased by relatives because she was HIV positive. 
 
“….when I found out that I was HIV positive I decided to commit suicide. I have just not 
managed because I cannot use my hands properly….” (Self-employed female 36yrs). 
 
“…When people at home tease me because of my HIV status, I wish to die so that I can leave 
them in peace with their things….” (Unemployed female 40+yrs co-infected with TB) 
 
♦Isolation 
One participant claimed that people in the community keep a distance from him because of HIV 
related symptoms, and this makes him feel uncomfortable and rejected. Other participants 
reported being rejected and being blamed by relatives because they were HIV positive. 
 
“In the community, people like me with skin problems suffer a lot, most people keep a distance 
thinking that if they accidentally touch me they will get my disease. I hear them whispering to 
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each other saying, „what else could that be, if not AIDS,‟ referring to my skin problem….” 
(Employed male 36yrs). 
 
 “One of my sisters has not accepted my HIV status, she blames me that I have done the biggest 
mistake of my life…” (Unemployed female 27yrs co-infected with other diseases). 
 
The defaulters confirmed that some of their friends distanced themselves from them when they 
found out that they were HIV positive. 
 
“…some of my friends are keeping a distance because they found out that I am HIV positive”. 
(Unemployed female 28yrs). 
 
♦ Rejection by partner 
Being HIV positive has contributed to mistreatment by partner and relatives resulting in patients 
defaulting treatment. One participant cited being left by her boyfriend the day she revealed her 
HIV status. Some relationships ended because of partners blaming each other. 
 
 “…My boyfriend left me the day I revealed my HIV status to him. Some of my friends are 
keeping a distance because they found out that I was HIV positive…” (Unemployed female 27yrs 
co-infected with other diseases). 
 
“…In bed my girlfriend doesn‟t want me to touch her. We even sleep in separate beds now….” 
(Employed male 36yrs). 
 
“…the issue of being HIV positive brought problems between me and my husband, he was 
putting the blame on me…” (Unemployed Female 28yrs). 
 
Some of the key-informants confirmed that mistreatment from spouses is common as most 
patients who defaulted complain of being neglected by a spouse or even being chased out of the 
house when their HIV status became known.  
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 “Mistreatment from the spouse is very common. Some husbands tend to neglect their wives or 
even chase them from their houses if they find out that they are HIV infected, even if both of them 
are infected, this leads to depression and in turn to poor adherence. “(DKI) 
 
“ …Just a day before yesterday a lady came looking for me crying and telling me that she 
stopped her treatment for a year hoping to die after her husband chased her out of the house, 
because of her HIV status and brought another women in the house,(staring at me she said) can 
you imagine?”(CCKI) 
 
 “…Yesterday I could just hear people arguing, saying:” you mean you brought me to this clinic 
were people with HIV are being treated?” and a lady just stood up and left the clinic, leaving a 
young lady behind. I later found out that it was a mother who brought her daughter to the PRE-
HAART clinic she was not aware what PRE-HAART stands for and immediately she found out, 
she just went away”. (NKI) 
 
♦Lack of family support 
The defaulters claimed they were disappointed with lack of family support since some of their 
family members kept their distance, which discouraged HIV positive persons to disclose their 
HIV status. 
 
“…Some of my relatives and friends kept a distance when they heard that I was suffering from 
HIV, they no longer pay me a visit…” (Unemployed female 28yrs) 
 
“ I stayed in hospital for a month but nobody visited me, my relatives could come for shopping at 
the shops nearby the hospital, but who gives a damn to come and visit somebody that is suffering 
from AIDS?... (Unemployed Female 40+yrs co-infected with TB) 
 
One of the participant’s attributes her lack of adherence to poor family support, since the person 
who used to remind her to take her treatment went away and she had nobody else who could 
fulfill that role. This led to her not being faithful with her treatment. 
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“….Sister I have no children of my own and I don‟t have a house. I am living with my sister, her 
son was the only one who cared about me and was very much supportive, he was the one 
reminding me to take my medications but since he moved to the South, now I am in trouble. 
Nobody cares about me…” (Unemployed Female 40+yrs co-infected with TB) 
 
All key-informants confirmed that many defaulters had poor support from their families and 
communities where they lived. According to the key-informants this was evidenced by those 
brought in by their relatives/friends to hospital and left alone at the clinic.  
 
4.2 Patient-related factors 
Individual factors relating to the patient, such as, poor understanding of the treatment regimen, 
forgetfulness, alcohol use, lack of commitment, personal beliefs, non-disclosure of HIV status, 
travelling and illiteracy influenced adherence, led to defaulting on ART in some cases. 
 
4.2.1 Poor understanding of treatment regimen 
Awareness of the importance of adherence as well as knowledge of the consequences of poor 
adherence, contributed to participants defaulting their treatment. 
 
♦Awareness of the importance of adherence 
Lack of understanding of the importance of treatment adherence contributed to patients dropping 
the treatment when they were feeling better. Participants reported they stopped taking treatment 
after they started feeling better. 
 
“When I started taking the ARTs, I only took them for a week or more then I threw them away 
since I started feeling better. I thought it was no longer necessary to take them…” (Employed 
male 36yrs). 
 
One of the key-informants was of the opinion that some patients had poor knowledge about the 
HIV infection including the importance of treatment adherence, and that this is the reason why 
they just stop taking treatment any time they feel like doing so. 
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“Sister, most people still have poor knowledge about the HIV infection therefore they just drop 
the medicine any time they feel like”. (Pharmacist assistant key informant (PAKI)) 
 
♦ Knowledge of consequences of poor adherence 
Some participants agreed that they did not have sufficient knowledge about the importance of 
taking medications on a regular basis. They reported discontinuing ART after experiencing side-
effects. They also cited medications not well explained to them; thus leading to poor adherence.  
 
“….At first the medications were not well explained to me. I think I did not understand 
everything. That is why when they made me feel sick, I stopped taking them…” (Employed Male 
36yrs co-infected with TB) 
 
“…I don‟t know exactly after how many hours I am not supposed to take the medicines after I 
forgot to take them at the right time……my friends told me that if I don‟t take those medications 
exactly the time I am supposed to take them and take them at a later stage the pills will kill 
me…” (Employed Male 36yrs co-infected with TB) 
 
One of the key-informants confirmed that although HIV and PRE-HAART counseling is 
provided to ill patients on admission, their relatives often do not ensure that post-discharge 
counseling is sought. This results in patients often not understanding the need to continue with 
treatment even if and when they feel better.  
 
“People who become very ill and end up being admitted in hospital and whose treatment is 
initiated while in hospital, HIV as well as PRE-HAART counseling is done to their relatives 
when they get better, most of the times their relatives don‟t take them for counseling therefore 
their understanding remains very poor.” (CCKI) 
 
♦Leftover pills 
According to one of the key- informants, patients ignore their follow-up dates and continue 
taking left over medications. Two pills are given in excess at the pharmacy every month, patients 
keep and take them and ignore their follow-up dates.  
 
 
 
 
43 
 
 
“…2 tablets are given in excess every month at the pharmacy. Some just continue taking those 
tablets and ignore their follow-up date.” (PAKI) 
 
“…I missed my follow-up because I was taking my left over pills while waiting to get money for 
transport. The problem comes when my medicine gets finished without me getting money for 
transport …” (Unemployed Male 30yrs). 
 
“…I had to travel to Windhoek urgently hoping not to stay for long. After all I had some left over 
pills, I was not worried but unfortunately I overstayed. My pills got finished and I also missed my 
appointment date...” (Unemployed female 27yrs co-infected with other diseases). 
 
4.2.2 Forgetfulness  
An overwhelming number of participants cited forgetfulness as a factor that contributed to poor 
adherence to medications especially when doing other tasks. Concentrating on work tasks 
contributed to forgetting to take medication at the prescribed times. One of the participants who 
has  defaulted several times and whose treatment has been temporarily stopped and sent for 
adherence counseling, claimed that forgetfulness was normal and she felt that she should not be 
blamed or punished because of it. 
 
♦Reminder of drug intake 
“…when I am busy doing other things I forget about the medications…” (Employed Male 
36yrs). 
 
 “…At work when I get preoccupied most of the times I forget to take my treatment, when I 
remember it is too late…” (Employed Male 36yrs co-infected with TB). 
 
“…sometimes I just forget and I think it is normal for somebody to forget…” (Unemployed 
female 27yrs co-infected with other diseases). 
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4.2.3 Alcohol use 
Some of the participants mentioned that using alcohol was a barrier to treatment adherence 
because alcohol contributes to their lack of memory. Participants also reported that work related 
exposure contributed to alcohol use which in turn led to treatment defaulting. 
 
♦ Difficulties to stop using alcohol  
One of the defaulters claimed to have been a heavy drinker before starting ARVs and is finding it 
very challenging to stop drinking.  
 
“…I was a true drinker. It is such a big challenge to stop taking alcohol…” (Unemployed Male 
40yrs). 
 
♦Lack of memory  
Alcohol intoxication impairs memory and leads to forgetfulness or ignorance of the time to take 
medications. This is confirmed by one of the participants in the current study who claims to be 
more forgetful after he consumes alcohol. 
 
“Sister having some few drinks with friends or alone makes me forget about taking my 
medications, -even if I am carrying them with me. I only remember the next day…” (Employed 
Male 36yrs). 
 
♦ Exposure 
Some participants cited finding it difficult to stop using alcohol because of peer influence. In 
addition bar attendants who are on ARVs also face challenges in avoiding alcohol when 
customers buy alcohol for them. 
 
“…when I go to bars with friends just to have one beer I forget about the medications. I only 
remember when I am at home but the time might be over to take them.” (Employed male 36yrs,) 
 
“I work in a bar, most of the times I am tempted to take some alcohol and forget to take my 
pills…” (Employed Female 37yrs co-infected with TB). 
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4.2.4 Lack of commitment 
Lack of commitment to ART has contributed to poor adherence. This is evident in some 
participants failing to take their treatment because of networking and peer-group influence. Some 
simply lacked self-motivation. 
 
♦Networking 
One of the participants reported that just thinking about socializing with friends as well as 
actively socializing often results in defaulting. 
 
“I like to enjoy with friends, when I go out with them hoping not to stay for long I find myself 
spending the whole day or even a weekend without taking my pills…” (Unemployed Female 
27yrs co-infected with other diseases). 
 
♦Peer group influence 
Peer group influence is reported to have affected one of the participant’s decision-making who 
said that he agreed with a friend not to go back for ARTs until they have fallen sick. 
 
 “I only went for HIV test when my best friend Titus requested me to escort him to the clinic to 
do an HIV test. My friend Titus also just decided to go because his girlfriend was forcing him to 
do the test, otherwise I thought it was not necessary because I was not sick….…. we were found 
to be HIV positive, then we agreed not to go back for ARTs until we become sick…….when I 
started treatment, I stopped treatment when I started feeling better.” (Employed Male 36yrs) 
 
♦ Lack of motivation 
Most of the participants defaulted on their treatment because of lack of motivation. For example 
those who misplaced their health passport did not inform the health-workers of the problem but 
instead waited for the misplaced item to be found at some stage.  
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 “…I defaulted for two months because my baby was admitted in ward 10 and a lady whose child 
was also admitted in the some ward and room with my child and whose baby was discharged 
earlier than mine she had mistaken her bag with mine and left with my bag where I placed my 
health passport…there is nothing I could do”. (Unemployed Female 28yrs). 
 
4.2.5 Travelling 
Participants’ who travel a lot reported that unplanned travelling contributed to treatment 
defaulting and poor adherence. 
 
♦Unplanned travelling  
Participants are faced with challenges such as unplanned travelling with friends or even work 
related commuting. This was supported by one of the key-informants who said that the defaulters 
reported that when traveling they sometimes forget their medications at home leading to 
treatment defaulting. 
 
 “…most of the times at work they just sent us to go and work outside this area and stay there for 
two days without telling one to prepare himself and they don‟t give you the opportunity to go 
home and get your medications, this makes it impossible for me to take my tablets for those days 
and if one was supposed to go for follow-up then one has to miss that appointment....” 
(Employed Male 46+yrs co-infected with MDR). 
 
“… Clients give several excuses of going to attend funerals or of travelling …..”  (DKI). 
 
4.2.6 Illiteracy 
Some of the defaulters indicated that they cannot read the instructions in their health passports 
and are unable to remember what has been said to them by the health-workers. Instead they 
depend on those who live with them who in turn tell them to wait until they run out of 
medication while waiting for the next appointment date. This also contributed them to missing 
their appointments and being poor adherents. 
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 “….Sister I don‟t know how to read and write. I depend on other people as to what time it is so 
that I can take my medications and to ask them to tell me when my follow-up date is. And guess 
what…most of the times I get wrong answers, I am told wrong follow-up dates, and when I come 
to the clinic it is either too soon to come or too late. The nurses are always mad at me but what 
can I do?” (Unemployed Female 40+yrs co-infected with TB) 
 
“…I think those that I am living with and claim to know how to read and write are also just like 
me,” illiterate,” how come they always tell me wrong dates?…” (Employed Male 46+yrs co-
infected with MDR) 
 
Participants who said that they did not have any formal education reported to experience 
problems in acquisition of knowledge on ARTs and they could not understand when instructions 
were given in the formal language which is English. They also indicated to have faced problem 
from instructions given in the languages known to them. According to the participants they 
needed instructions’ to be repeated to them several times before they could grasp what has been 
said. 
 
“….the mistake is mine, I don‟t grasp things easily, one should tell me several times for me to be 
able to understand. Even the medication they are giving me, I don‟t know really how to take 
them. I cannot read and write…” (Unemployed Female 40+yrs co-infected with TB) 
 
“…I started ARTs in Walvis Bay. In Walvis Bay most people don‟t speak Oshiwambo. Therefore 
the nurse was speaking in English and I don‟t understand a word in English. The one I went with 
to translate for me, she couldn‟t clarify every question that I was asking her. I think she also 
doesn‟t understand everything…” (Employed Female 37yrs co-infected with TB) 
 
4.3. Health service factors  
Participants cited various health system factors that were negatively affecting adherence, namely:  
long distance to health facility, shortage of staff at the clinic, poor patient-health provider 
relationship and the attitudes of health providers.  
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4.3.1 Long distances to health facility 
♦Transport cost 
Most participants highlighted that they come from very far. They cited distance to the clinic and 
not having money for transport as a key problem to adhering to follow-up appointments. 
 
“…I don‟t have a job and I travel as far as from Okahao to get my medicines. Most of the times I 
don‟t have money for transport but once in a while my friends as well as my family, when they 
have money they help me out…” (Unemployed Male 30yrs). 
 
 “…….The distance to the clinic is very long for some clients, for example people coming from 
Uvudhiya which is more than 60km away from Oshakati and this is the only nearest Hospital 
that is providing ARVs….”(PAKI). 
 
4.3.2 Shortage of staff at clinics 
Most of the defaulters highlighted overcrowding at the clinic to have contributed to some of the 
participants leaving the clinic without being attended to, due to other commitments. They 
complained about the noise at the clinic that makes it difficult to hear their names when called by 
HCPs. This contributed to being attended to very late and eventually leaving without 
medications.  
 
“I do afternoon shifts until midnight and because of the delay at the clinic most of the times I go 
to work late and very exhausted because there is no time to rest… because this clinic is always 
very full”.” (Employed Male 46+yrs co-infected MDR) 
 
“…..people make noise at the clinic and if one tells them to keep quiet, they will ask you if you 
don‟t have ears and worse enough the nurses call our names in a very low tone, if you don‟t 
answer they will put our health  passport aside and call you only when everybody else is 
done…” (Unemployed Male 39yrs co-infected with TB). 
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“This clinic is most of the times overcrowded every day, it is a very busy clinic some people work 
and when they find the clinic very busy they get very much discouraged to join the queues, and 
they might fail to find a suitable time to come back.….. Therefore people who work end up 
dropping the medications and only come back when they are feeling very sick.”(NKI) 
 
♦ Lack of order 
The majority of participants listed lack of order at the clinic to have contributed to 
disorganization, since young people who come late to the clinic squeeze themselves in front of 
elderly people who come very early to the clinic. Therefore those who come very early are seen 
last by the doctor and end up leaving without treatment because by the time they reach the 
pharmacy it is too late and the pharmacy is closed. 
 
 “….there should be some order at the clinic, the youngster‟s squeeze themselves in front and 
then end up being attended to first… a security guard should be allocated to the clinic to put up 
some order….people that come late insert their health passports under those belonging to the 
people who come first and they end up being treated first…” (Employed Female 36yrs). 
 
“…at the reception, there is just no control or order we are told to put our health passports in a 
box to be collected later by the nurses but most of the times those that come early end up being 
treated last…”(Employed Male 36yrs co-infected TB). 
 
“….most people who come from very far and who could have come early to this clinic end up 
being treated last and living without their treatment because when you reach the pharmacy you 
will find it closed that has happened to me several times….” (Employed Male 36yrs). 
 
♦Long waiting time 
A few defaulters raised complaints about long queues at the clinic. The waiting times were very 
long and contributed to them becoming frustrated and eventually defaulting their treatment.  
 
“…. I wonder if it is not possible for this clinic to open during lunch hours this place is always 
very crowded…” (Employed Male 36yrs co-infected TB). 
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“…most of the times one leaves this clinic feeling very sad … why don‟t they employ more 
nurses?” (Self-employed Female 36yrs) 
 
 “… This clinic is always very full, it is really discouraging…people working at the clinic are 
very slow, I would like them to change their speed, because of their speed you will find the 
pharmacy closed that has happened to me several times….” (Employed Male 46+yrs co-infected 
MDR) 
 
“……The waiting time is too long Sister, starting at the reception; this is all because of the 
number of patients attending the clinic…..”(CCKI) 
 
“….It is really discouraging because a client coming for follow-up has to spend the whole day at 
the clinic ….really something needs to be done to minimize the time of stay at the clinic.” (DKI) 
 
According to one of the participants the issue about long queues at the health facility was 
demotivating and has contributed to his defaulting behavior. 
 
“My God… I get so much discouraged when I entered this door and saw such long queues” 
(Unemployed Female 27yrs Co-Infected with other diseases). 
 
“….Sister (Referring to the researcher) the queues in the clinic are too long and also many, one 
may need to join the queue to the doctor‟s consulting room, to the blood room as well as to the 
pharmacy, if somebody is in a hurry then it is just impossible,” (PAKI). 
 
“…The hospital staff has requested if possible to be provided with a separate box where they can 
put their Health passports and have a different queue, we are still looking into that.” (CCKI) 
4.3.3 Poor patient-health provider relationship 
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Although participants reported to be generally satisfied with the quality of care at the health 
service facility, some reported that the patient-health provider relationship was characterized by 
lack of empathy, lack of trust and negative attitudes of HCPs 
 
♦ Lack of empathy 
Some defaulters reported HCPs’ attitudes to be unfriendly, not very helpful and they do not pay 
attention to their problems, which contributed to them being non-adherent to their treatment. 
 
“At the pharmacy even if the doctor prescribes medications enough for two months they refused 
to give all of them. They will tell you to come next month…” (Unemployed Male 40yrs). 
 
 “...I asked the doctors several times to give me a transfer later to the nearby clinic but they are 
taking too long. Imagine it‟s now a year that I am struggling to get that letter….” (Unemployed 
Female 28yrs) 
 
It is so discouraging coming for follow-up visits because the doctor doesn‟t pay attention to the 
other problems that I am having. Look at my skin; I keep complaining about it but he just ignores 
me. He doesn‟t even refer me to other doctors. He just tells me to go to the pharmacy to get 
ARTs…” (Employed Male 36yrs). 
 
“….the health care providers should put more emphasis on giving health education and 
encouraging us to live a positive life and refrain from criticizing us…” (Employed Male 39yrs 
co-infected with TB). 
 
♦ Lack of trust 
According to some participants, the negative client-provider relationship contributed to lack of 
trust and eventually influenced the adherence of patients negatively. Participants reported some 
HCPs do not pay attention to what they are telling them and cited doctors and nurses giving them 
unpleasant answers. 
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 “I find the service at this clinic not good because the service providers don‟t listen to what one 
is asking or telling them. Instead they reply saying that it seems I know it all….” (Employed 
Male 36yrs). 
 
 “Doctors and nurses don‟t understand my problems they always think I am laying when I am 
telling them the problems I am having that cause me to default…‟ (Unemployed Female 28yrs). 
 
In addition, the key-informants reported that some defaulters leave the clinic when they 
encounter nurses known to them at the clinic. 
 
“The clients that are from our areas if they find us here they just disappear without treatment 
and perhaps don‟t come back anymore until they are very sick, “(NKI) 
 
 
 
4.3.4 Negative attitudes of health providers 
Most defaulters were dissatisfied by the negative attitudes of the nurses. Those who default their 
treatment feared to go back to the clinic. Defaulters cited nurses and doctors being very rude to 
them and these negative attitudes of the HCPs are demotivating thus contributing to non-
adherent behavior. 
 
“…some of the nurses and doctors at the clinic are very rude; the way they talk to us is not good 
it makes me feel very unwelcome…….When I defaulted my treatment I became extremely scared 
I feared this rude nurses, it is my family who brought me back when I became sick….” 
(Unemployed Female 27yrs co-infected with other diseases). 
 
 “…Sometimes at the pharmacy they give us wrong treatment but when we ask them they give us 
unpleasant answers…” (Employed Male 36yrs co-infected with TB). 
 
“The health providers should just reframe from criticizing us…” (Unemployed Male 39yrs). 
 
 
 
 
53 
 
 
 “…some health workers have sharp tongues, they answer us in a very rude manner when we are 
asking for directions or just something…” (Self- employed female 36yrs). 
 
 
4.4. Socio-economic factors 
Socio-economic factors that have emerged from the study and negatively affected adherence 
were: unemployment, lack of transport and floods. 
 
4.4.1 Unemployment  
Unemployment was a key factor that caused defaulting on treatment among some participants. It 
contributed to some participants not being able to afford buying food to take with medication. 
Factors such as lack of transport money and work related migration also contributed to poor 
adherence. 
 
♦ Lack of food 
 “…I am not employed, my family depends on me only and on our millet field but sometimes the 
rainfalls is poor and I just don‟t have enough food to take those pills and also don‟t have money 
to buy food or to go to for follow-up visits…” (Unemployed Male 39yrs co-infected with TB). 
 
“ “...I am unemployed my husband is unemployed and I have children as well as my brothers 
and sisters to take care of, it is difficult to get enough food to take this pills and to have money 
for transport  to go for follow-up visits…” (Unemployed Female 28yrs). 
\ 
“…sister I asked for assistance from the CDC staff to assist me with food but they say they don‟t 
do so, I also approached one of the non-governmental organizations for food assistance but they 
also said that they don‟t provide food…… When I don‟t have enough food and take both 
medications for TB and ARVs I feel very nauseated…therefore sometimes I don‟t take the 
treatment” (Unemployed Male 39yrs co-infected with TB). 
 
 
 
 
54 
 
 
“yah, poverty is a big problem and I am certain about that, when we used to go for field work 
with sister Diana (not the real name) during 1998, 1999, 2001, 2002, 2003 and 2004 you could 
enter a house hold and if you just enter like this, you really see that there is nothing in the house 
and you truly wonder how this people are surviving. (CCKI) 
 
 “Some clients who have defaulted tell you that they don‟t have enough food and if they take the 
medicine on an empty stomach they don‟t feel well.”(PAKI) 
 
An overwhelming number of the defaulters claimed to default their treatment because of not 
having transport money. Participants cited failing to go for follow-ups visits and to collect their 
medications from the clinic because of lack of transport money. On the other hand, lack of 
transport money did not prevent some patients from coming for their treatment as one defaulter 
reported that most of the time he was given transport money by friends and relatives. 
 
“…most of the times I don‟t have transport money and I thank the hospital for providing this 
service for free because before they started doing so I used to suffer very much…” (Unemployed 
Male 39yrs co-infected with TB) 
 
 “Sometimes they just tell you that they don‟t have transport money …” (DKI) 
 
♦ Work-related migration 
Some of the defaulters claim they could not find employment in Namibia and ended up working 
in a neighboring country, such as Angola, hence they cannot afford to return regularly for 
monthly follow-ups.  
 
“Some of us failed to get employment here, I got a job in Angola and coming over so frequently 
is not always possible…” (Employed Male 36 yrs.). 
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“… I work in Angola and at work it is compulsory for me to stay there for two months to be 
given day-offs, this makes life difficult because I am supposed to come for follow-ups every 
month…” (Employed Male 46+yrs co-infected MDR). 
 
4.4.2 Unavailability of transport 
Defaulters from villages far away from Oshakati (the town where CDC is located) reported it 
was difficult finding transport to the hospital. There is no public transport and very few people 
own cars in their villages. Thus they have to rely on other villagers who own vehicles to 
transport them to hospital.  
 
♦ Inability to go for follow-ups 
“Sister at our village there is just one Car that comes to Oshakati (the town where CDC is 
located) if the car breaks down what can I do? And the car only comes once a week, definitely I 
will miss my appointment.” (Employed Male 36yrs co-infected with TB). 
 
.”There are very few transport vehicles coming from some villages perhaps once per week and if 
there is a car coming here then everyone in the village is supposed to know or otherwise one may 
end up missing it.” Now imagine what happens when that car is broken or if the owner has just 
decided not to go to town for a longer period?” (NKI). 
 
♦ Floods 
Most participants cited floods as having contributed to them not being able to access the health 
facilities leading to them defaulting treatment. When it rains most of the villages in the Oshana 
Region, where the study was conducted, become encircled by the flood waters making it 
completely impossible to reach or leave those areas. 
 
“When it rains there is no way I can get out of our area because it is surrounded by waters, but 
when I tell these doctors they think I am lying.” (Employed Female 37yrs co-infected with TB). 
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….”During the raining seasons most of the places in the region are surrounded by rain waters 
making it difficult for those living at those areas to come for their follow-ups, you know floods 
are very common her in the North.…. Therefore most of them have to wait until the water level 
goes down or dry up so that they can come for their treatment.” (NKI) 
 
“……We sometimes reach those places with an helicopter that is being utilized for PHC services 
but for the past two years we have not done so, we don‟t carry outreach services, we don‟t even 
have enough staff or transport to carry out such services.” (NKI) 
 
4.5. Work place factors 
Participants mentioned work related pressure and their respective employer’s lack of support as 
hindering factors for good adherence. Patients do not disclose their HIV status for fear of losing 
their jobs. On the other hand those that disclosed their status faced challenges of having to 
choose between work and going to hospital since their employers most of the times will not let 
them leave work. 
 
4.5.1 Work related pressure 
♦ Losing jobs 
Participants claim to be challenged by work related pressure, such as discrimination and fear of 
losing their jobs. The defaulters felt that disclosing their HIV status to their employers and 
colleagues might contribute to discrimination in the work place. 
 
“……my boss is not aware about my HIV status. This makes things more difficult because he will 
not understand why I should go to hospital every month. I fear to tell him because maybe he is 
going to fire me....” (Employed Male 36yrs co-infected with TB). 
 
“Those that are working did not disclose their HIV status to their bosses. Not disclosing makes it 
difficult for them to tell their bosses every month that they are going to hospital.” (DKI) 
 
 
 
 
 
57 
 
According to some of the participants, although their employers are aware of their HIV status life 
is difficult for them, because their employers make them to choose between their job and 
treatment. 
 
 “…my boss told me several times that if I want to go for my treatment I should quit this job, I 
cannot do that Sister I am the only bread winner for my family…” (Employed Male 46+yrs co-
infected MDR). 
 
Some of the defaulters claim to be willing to go for their treatment but because of the fear of 
losing their jobs or to have money deducted from their salaries they find it difficult to adhere to 
their treatment. 
 
“….when I go to hospital and fail to turn up at work my boss deducts money from my salary. 
(Employed Male 36yrs) 
 
”…If there is shortage at work i just have to go to work and miss my follow-up date, my boss 
only allows me to go when there is no shortage at work…” (Employed Male 46yrs co-infected 
with TB). 
 
One of the key-informants verified that some of the defaulters reported about their willingness to 
go for follow-ups and about their bosses not letting them. 
 
“Those that are working will tell you that it is not easy to leave their work to come to the 
hospital, most clients are willing to come to the clinic but their bosses will not let them.”(DKI) 
 
4.5.2 Lack of support from employers 
Participants cited lack of encouragement from their bosses and work related travel as factors that 
affected non-adherence. Participants reported their bosses did not encourage them to take their 
treatment and some made them to be disqualified from being given ARTs because they followed 
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them to the clinic and forced them to leave the clinic unattended which contributed to poor 
adherence.  
 
♦Encouragement 
 
“…..I have not been on ARVs for a very long time because my boss just turned up at the clinic 
and he was quarrelling and demanding that he wants to see “me” Markus Simon he made me to 
be disqualified I left the place without being attended to because he refused to listen to what the 
nurses had to tell him and the counselors wrote in my health passport that I am not qualified to 
be given ARTs….” (Employed Male 36yrs). 
 
“…my boss is somebody who doesn‟t understand his employee‟s problems, what matters to him 
is only his work…” (Employed Male 46+yrs co-infected with MDR). 
 
One of the key-informants reported to have experienced employers following their employees to 
the clinic and making them leave the clinic without being attended to. 
 
“My dear, I have come across employers coming to our clinic to ask the doctor what is wrong 
with their employees, because they themselves are not free to tell, I have also come across those 
who lose their jobs after their bosses found out that they were HIV positive.”(NKI)  
 
Although participants reported to be generally dissatisfied with the way their employees are 
treating them, some reported that they had not experienced problems taking their tablets at work. 
 
“…I don‟t have a problem taking my pills at work the only problem is just that it is not easy to 
go to the clinic for follow-up visits or for my treatment…...” (Employed Male 37yrs co-infected 
with TB). 
 
4.6. Treatment related factors  
Some defaulters cited treatment side-effects, treatment fatigue as well as complexity of the 
treatment process as hindering factors for good adherence. 
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4.6.1 Adverse Drug Reaction 
♦ Side-effects 
Some participants reported discontinuing medications as a result of adverse drug effects such as 
vomiting, nausea, mental confusion and skin rashes.  
 
“….vomiting makes me not to take my medications sometimes…” (Unemployed Male 30yrs). 
 
Sister I had to stop those treatment cause I felt I was going crazy, when I lie down I fell as if all 
the objects  are falling on top of me (she lifted her hand and made circular movements with her 
finger and said :) actually my head was spinning, therefore I dropped both treatment for TB and 
those for HIV.” (Employed Female 37yrs co-infected with TB) 
 
 “… When I don‟t have enough food and take both medications for TB and ARVs I feel very 
nauseated…” (Employed Male 46+yrs co-infected with MDR) 
 
“….the medications make me feel dizzy…” (Unemployed Female 28yrs). 
 
 “Some of the clients have stopped taking the medications because of the drugs negative 
effects.”(DKI) 
 
4.6.2 Treatment fatigue  
♦ Pill burden 
Participants reported pill burden to negatively influence adherence as participants who are on 
combined treatment said they are tired of treatment. 
 
 “…I always force myself to take those tablets….sometimes I just feel tired to take those pills 
imagine taking both TB and those for HIV?” (Employed co-infected with TB Male 36yrs) 
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“I take two treatments for TB as well as ARTs the pills are big, I always get the feeling that they 
are going to get stuck in my throat, I have to always force myself to take them…” (Employed 
Male 39yrs co-infected with TB) 
 
In conclusion the chapter highlights the findings of the study. Six major themes and various sub-
themes were identified from the study as key factors that contributed to poor ART adherence. 
The next chapter discusses the findings of the study. 
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CHAPTER 5: DISCUSSION 
 
5.1 Introduction 
This chapter presents the discussion of the study findings together with reference to relevant 
literature. The discussion centers on the factors that emerged from the interviews with key- 
informants as well as from the in-depth interviews with the defaulters. Factors identified include: 
social, patient, health service, socio-economic, unplanned ART interruptions, work as well as 
treatment related factors. 
5.2 Faith in healing 
This study found that some participants stopped taking their medications because of religious 
beliefs and influences. Although, according to Parsons et al. (2006), the literature suggests that 
church attendants and spiritual believers are more likely to adhere to treatment. However some 
religious beliefs can have a negative impact on adherence due to stigma associate with 
HIV/AIDS. The findings of an exploratory study, conducted amongst HIV individual in the 
Southern State, to find out about patients attitudes and beliefs surrounding HIV infection and 
adherence to treatment, revealed that even though certain religious practices are positively 
associated with adherence there are certain religious beliefs that affect adherence negatively 
(Ware et al. 2009). According to Ware et al. (2009) conflicting messages from religious 
authorities and health-care practitioners may also interfere with adherence. However, it is equally 
important for HCPs to have a better understanding of patients’ religious beliefs that may have a 
negative influence on adherence in order to develop adherence strategies that will benefit their 
clients. 
5.3 Traditional therapies 
Oshakati town, where CDC is located and where the study was conducted, is surrounded by 
many villages where people are still loyal to their cultural and traditions beliefs. According to 
Ware et al. (2009) cultural and social obstacles threaten treatment adherence. In the current 
study, it emerged that some ARVs defaulters where convinced and believed that they were 
bewitched or that their disease could only be treated with traditional medicine. They admitted to 
having stopped their treatment and to have sought help from traditional healers. According to 
Rowe et al. (2005) some traditional healers claim to cure HIV and many people have fallen prey 
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to such claims because orthodox HIV treatment only slows the progress of the disease and does 
not cure it. This has consequently contributed to patients abandoning their treatment or 
combining it with traditional medicines causing interference in drug levels. Some participants in 
the current study stopped their medications after consulting traditional healers because of the 
belief that traditional medicine cannot be mixed with western medications. Peltzer, Friend-du-
Preez, Ramlagan and Anderson (2010) indicated that using herbal medicines for HIV was 
associated with lower adherence. 
 
According to a study conducted, at the ThembaLethu Clinic at Hellen Joseph in Johannesburg, 
on patients who missed follow-up appointments, it was found that a decision to try traditional 
medicine was one of the reasons given for non-adherence (Maskew, MacPhil, Menezes & Rubel, 
2007). Another study conducted in a district hospital in KwaZulu-Natal, South Africa, found 
similar results: most of the defaulters cited that they were cursed and could only be treated by 
traditional healers (Govender & Marsh, 2009). Convening to WHO (2006), beliefs that people 
have been bewitched, afflicted by an AIDS devil/spirit, or had a spell cast on them are known to 
have a negative influence on adherence. In a study done in Botswana by Weiser et al. (2003)  
47% of the patients interviewed  acknowledged the use of traditional remedies for HIV infection 
and 21% anticipated visiting a traditional healer in the future for treatment the disease. It is 
therefore important for HCPs to have some understanding of their clients’ cultural backgrounds 
that might have an influence on treatment defaulting. There might be a need for collaboration 
between traditional as well as western medicine to enable patients to completely adhere to their 
treatment. A study done in Burkina Faso demonstrated positive outcomes on adherence when 
traditional healers were involved in the management of certain diseases (Sanou et al., 2004). It is 
suggested that health-workers recognizing patients’ social or physical environment since HCPs 
and patients come from a variety of cultural backgrounds with different beliefs it is important to 
understand those beliefs that might affect treatment adherence (Senelgroove, 2006). 
 
5.4 Influences of stigma and discrimination 
An HIV/AIDS diagnosis is believed to contribute to stigmatization and discrimination among 
some HIV patients. The stigma surrounding AIDS is primarily caused by poor knowledge, fear 
of disease and death, sexual behaviours, as well as poor acknowledgement of stigma (Theron, 
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2005). The issue of HIV stigmatization still remains a major problem (WHO, 2006). According 
to the findings in this study some of the participants interviewed admitted to not disclosing their 
HIV status for fear of discrimination and rejection. According to Ware et al. (2009) stigma is 
feared because it contributes to social isolation and affects relationships that are essential for 
survival. Conferring to Nachega, Mills and Schechter (2010), a systematic review in developing 
countries indicated non-disclosure to loved ones or fear of being stigmatized to be the most 
important and common factor contributing negatively to adherence. In a study conducted in 
Botswana that aimed to elicit principal barriers to adherence it was found that 69% of the 
respondents claim not to have disclosed their HIV status to their family members because they 
feared being ostracized, rejected, or a break-up of their marriages, and 94% kept their HIV status 
a secret from the community. Amongst the participants 15% reported stigma as a barrier to 
adherence (Weiser et al., 2003). According to one of the participants in the current study her 
relatives refused to eat her food when they found out about her HIV status. They told their 
children to not to eat her food or even touch it. This finding is in line with those reported by 
Ware et al. (2009), namely, when a set of friends found out about a patient’s HIV/AIDS status 
everybody withdrew from eating from the same food container as him.  
 
The study findings also show that some participants failed to take their treatment in the presence 
of friends or to discuss their illness with families and neighbors for fear of what others might say 
and suspect. These findings are in line with what is reported by Ware et al. (2009), namely that if 
patients are seen taking ART by family members, neighbors, or friends, this is likely to convey a 
signal that they are HIV positive and living with AIDS. The reason given by patients for not 
taking medications is because they are not comfortable taking them in front of friends, families, 
and co-workers (Ware et al., 2009). Stigma and fear to disclose their HIV status both contribute 
to patients skipping their doses if privacy is unavailable at a scheduled dosing time. This leads to 
attempts to hide the medication and to change dosing schedules which contribute to non-
adherence (Klitzman et al., 2004).  
 
Findings from the study also indicate that some participants travel long distances to go to health 
facilities far from their area where they are not known, and some leave the clinic unattended 
when they find someone known to them in the clinic. According to Theron (2005) many 
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educators infected by HIV choose to relocate once they become visibly ill or they simply 
disappear leaving classes without educators. The problem of stigma and negative attitudes in the 
family and community settings raised in this study is supported by Mills et al. (2006) who 
reported that 34 qualitative studies in developed countries, as well as two qualitative studies in 
developing countries, recorded individual themes of barriers to treatment adherence; these 
include fear of disclosure and waiting to avoid taking medications in public places. Stigma and 
discrimination reported in the community, within the hospital setting, and even among the family 
members, are regarded as a matter of concern since these led to some patients to pursue HIV 
treatment at distant clinics resulting in lack of family and social support. 
 
5.5 Lack of family/social support 
The negative influence that social support has on ART adherence as shown in this current study 
has been well documented (Remien et al., 2002; Weiser et al., 2003). Some participants reported 
that the behavior of community members, as well as family members, changed towards them 
when they found out about their HIV status. Difficult family circumstances in South Africa are 
reported to have contributed to high rates of migration, teenage pregnancy, overcrowded living 
conditions, family violence, and substance abuse. These are factors that are likely to create 
conditions under which family and social support are poor which in turn contribute to 
compromised adherence rates (Wood, Tobias & McCree, 2004; Koopman et al., 2006). On the 
other hand this study also found that some participants did receive support from their friends and 
families. According to Nachega, Mills and Schechter (2010) qualitative studies conducted in 
South Africa examining social support networks and relationship indicated patient support to be 
very important to treatment adherence. Research studies conducted in Nigeria, Tanzania, and 
Uganda, also demonstrated that social relationships are particularly important in treatment 
adherence. 
 
5.6 Poor understanding/knowledge  
The current study identified that poor knowledge, or a lack thereof, about ART as being a 
leading factor that contributed to treatment defaulting. Some of the defaulters interviewed in this 
study reported to have defaulted after they felt better; they thought that they need to only take 
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medications when they were not feeling well. According to Ware et al. (2009), behavioral 
obstacles, such as stopping drugs when symptoms disappeared, have been reported in studies 
done in Sub-Saharan regions as well as elsewhere. Similar trends were noticed in Botswana, by 
Weiser et al. (2003), where 8% of the patients stopped treatment as soon as their symptoms 
disappeared. Some participants do not know exactly at what time the medicines are supposed to 
be taken and therefore, do not take their drugs at the prescribed times. Some only take the drugs 
once they start feeling sick because they do not know the importance of uninterrupted treatment 
while others claim that the instructions are not clear; such actions leads to inappropriate use of 
the drugs. According to Mills et al. (2006) some patients missed their treatment simply because 
they did not understand the instructions. The findings in this current study clearly indicate that 
the instructions regarding when to take and not take the pills are not well communicated. This 
clearly indicates that there is lack of adequate communication with the patients during their visits 
at the health facility. These findings are consistent with studies done in Malaysia, Gambia and 
Ethiopia in terms of poor knowledge about the length of treatment contributing to treatment 
defaulting because due to poor health worker/patient relationship it was found that patients were 
not informed about the duration of the treatment (Tekle, 2002). Therefore personal factors are 
often reinforced and influenced by the health-workers. Failure to communicate adequately with 
the patients leads to poor knowledge and eventually to non-adherence to treatment. The findings 
of a study done by Hasker et al. (2010) underscore that poor communication between patients 
and health providers contributed to patients defaulting their treatment when they started feeling 
well or when they did not see any improvement in their health. According to these authors 
treatment defaulters lack knowledge about their disease. The above mentioned findings are 
supported by Ley’s theory that indicates that compliance can be predicted by a combination of a 
patient’s satisfaction with the consultation process and understanding of the information 
provided as well as recall of this information (Olivera, 2009). Therefore, health-workers should 
utilize this model by following Ley’s 1989 suggestion that the level of understanding and 
accuracy of recalled of information may be improved if it is ensured that patients understand and 
are able to recall the information given to them.  This can be achieved by: giving information in 
a simple way; repeating the important aspects; being specific; putting emphasis on the 
importance of compliance; making sure that patients remember the first part of the message; 
scheduling additional follow-up interviews (Olivera, 2009). 
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5.7 Impact of alcohol use on treatment adherence 
Alcohol abuse is a factor that hinders adherence in terms of the findings of this study. Some 
participants cited alcohol intake as causing them to forget to take their medications. According to 
a systematic review conducted by Nachega, Mills and Schecheter (2010) alcohol intake was 
amongst the factors reported to negatively impact on adherence in developing countries. More 
recent studies of patients who were receiving multidrug regimens suggest that use of alcohol is 
associated with non-adherence (Gifford et al., 2000). Jaiswal et al. (2003) indicate that TB 
patients who abuse alcohol do not collect their treatment regularly as compared to those who are 
teetotalers. Consuming alcohol when on treatment may have devastating effects on a patient’s 
mental stability, such as contributing to either forgetting to take the treatment or influencing the 
effectiveness of the prescribed medications that are being taken (Cramm, Finkenflugel, Moller & 
Nieboer, 2010) The above mentioned findings support Ley’s model of compliance that indicates 
that mental instability negatively influences a patient’s ability to recall the information which 
contributes to non-adherence (Ogden, 2000). 
 
5.8 Illiteracy  
One of the critical issues that emerged from the study is poor literacy. Some of the participants 
claim to be completely illiterate while most of them have very low levels of education and 
cannot communicate in English (the official language in Namibia). They therefore lacked the 
ability to read the instructions given by the HCPs which in turn contributed to them not adhering 
to treatment or to follow-up appointments. These findings are in line with those from a cohort 
study by Golin et al. (cited by Paasche-Orlow et al., 2006), who followed patients on a new ART 
regimen for 48 weeks and reported low health literacy to be associated with poor knowledge of 
the regime and they concluded that low health literacy was a barrier to adherence early in the 
course of treatment. According to Bosworth and Oddone (2002) a large percentage of patients, 
particularly the elderly, do not understand directions. A cross-sectional study done in the USA 
reported that the proportion of Americans who read the least were 16% of those e between 45-54 
years old, 26% for those between 55-64 years, and 44% of those who are 65 and above. In terms 
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of health issues it was found that 26% were unable to understand information pertaining to next 
scheduled appointments (Bosworth & Oddone, 2002). 
 
Low literacy in patients is associated with inadequate disease related knowledge and self-
management, the worse self-reported health status, and poor treatment adherence (Peltzer et al., 
2010; Powell & Kripalani, 2005). These authors consider physicians to overestimate their 
patients’ literacy levels despite ample evidence that they may also not consider limited literacy 
skills as factors in patient care. This study’s finding justifies the need for improved 
communication skills between the HCPs and their patients in terms of Ley’s model of 
compliance which considers patients understanding to be the cornerstone of the patient’s ability 
to adhere to treatment (WHO, 2003). HCPs should make sure that their patients are clear about 
the timing of the treatment instructions and all the aspects involved in their treatment (Munro et 
al., 2007a). 
 
5.9 Influence of poor relationship between health-workers and patients 
A good relationship between health- workers and their patients is extremely important given that 
a poor relationship can negatively affect adherence. For instance, in the current study some 
patients become too scared to return to the health facilities when they missed appointments or 
fail to take their drugs correctly, for fear of the health-workers’ reactions. A review by Munro et 
al. (2007a) and a study by Hasker et al. (2010) indicate that reasons associated with defaulting 
include the poor attitudes of health-care workers, such as scolding the patients for missing 
appointments and/or refusing to give defaulters more medications. However in the current study 
some participants had no problem with the HCPs and were happy about the service provided at 
the health center. These findings are in line with those reported by Weiser et al. (2003) in a study 
conducted in Botswana, namely that 96% of the patients cited that their providers treated them 
with respect and dignity. Interpersonal relationship can positively or negatively affect adherence 
behaviors. According to Mills et al. (2006) positive interpersonal relationships between HCPs 
were reported in 17 studies as facilitating and necessary for successful adherence. However 
negative attitudes of HCPs can cause patients to not use a clinic which would then compromise 
the quality of care they are entitled to receive. 
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5.10 Barriers of accessibility to treatment  
Some participants in the current study raised concerns about having to cover long distances to 
the health facility especially since there is lack of public transport. Long distances to facilities 
that provide ARVs remains a crucial issue to ARV defaulting. According to Nakinyemba, Kweza 
and Akurut, (2004) in Uganda, distance, transport, and finance, were found to be barriers to 
adherence. Some participants reported travelling 50-130 kilometres (kms) or having to cross 
rivers in order to access the health services. A study in Addis Ababa found that patients walked 
for up to two hours before reaching the nearest health facility (Demisse, Lindhtjorn & Berhane, 
2002). In this study participants claim to have defaulted treatment because of floods that are 
common in the area during raining seasons. According to Veenstra, Whiteside, Laloo and Gibbs 
(2010) in Southern Africa there are a huge range of different crises that can potentially 
undermine ART treatment. For example, the 2008 floods in Mozambique are known to have 
contributed to several health-related problems including poor access to health care. These points 
illustrate a need to further decentralize the access to ARVs to clinics or to purchase a vehicle to 
enable outreach services and a helicopter to reach areas that are inaccessible during raining 
seasons. 
 
5.11 Impact of socioeconomic factors on treatment adherence 
The financial difficulties experienced by the population group in this study are important as most 
people who attend the clinic are unemployed and are from far villages. Financial difficulties 
were commonly cited as a reason for not returning for clinic visits or for defaulting treatment. 
Currently patients in Namibia do not pay fees for health services at health centers but many do 
travel long distances to the clinic as ARVs are not available at their local clinics. Some of the 
participants in this study claim to have defaulted because of lack of transport money to the health 
facility. These finding are in line with those reported by Greene (2004) since in a study done in 
Bolivia it was found that patients who defaulted their treatment claimed not to have money for 
transport to health facilities. A study, conducted in South Africa on patients who missed follow-
up appointments, highlights financial difficulties to be a leading cause of the problem since 34% 
of those who missed their appointment said it was because of financial problems (Maskew, 
MacPhail, Menezes & Rupel, 2007).  
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High unemployment rates are associated with low socio-economic conditions and are considered 
to have a negative impact on treatment adherence (Gelmanova et al., 2007; Low, 1995). In the 
current study the participants who are employed reported to be the sole family bread winners and 
the whole family, as well as extended family, depend on them. Some are employed in 
neighboring counties and claim to have problems to come for follow-ups contributing to non-
adherence. According to Ware et al. (2009), travelling a long distance to attend clinical 
appointments places additional economic strain on patients and their families by competing with 
income generating activities which eventually leads to ARV interruptions. Lack of enough food 
was highlighted by the participants as contributing to their failure to take medications. 
Bezuidenhout (2004) considers inadequate financial or social support such as social grants, to 
have contributed to poor people’s inability to acquire nutritious food in order to maintain a 
healthy status. In a study conducted in South Africa it was found that successful completion of 
treatment was attributed to the availability of food as patients did not take medications on an 
empty stomach which could exacerbate treatment side-effects. Moreover taking treatment on an 
empty stomach can make patients sick and cause them to default treatment (Zvavamwe & Ehlers, 
2008). Therefore expanding the ARV programme to include provision of food will benefit lots of 
patients who cannot afford to buy nutritious food seeing as they depend on their millet fields for 
sustenance. 
 
5.12. Lack of employers, support 
Some participants claim to have missed their follow-ups because they had to choose between 
keeping their jobs or seeking health care. In a study conducted by Greene (2004) it was reported 
that some patients defaulted treatment in order to retain their jobs. Participants who are co-
infected with TB claim they face the biggest challenge since they have to go for follow-ups for 
TB treatment and for ARVs. According to Munro et al. (2007a), various studies indicate that 
having TB has employment and work related consequences. Some of the participants in this 
study said that their bosses deduct money from their salaries for the days they are absent from 
work when they attend the hospital. Patients are considered to hide their disease because of work 
related issues which include fear of job loss or dismissal (Munro et al., 2007a). This therefore 
warrants the need to involve employers in the treatment of their employees. For example, to 
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either support employees to adhere to their treatment regime or to encourage them to go for their 
follow-up visits. 
 
5.13 Medication related factors 
In the current study it emerged that treatment side-effects impacted on treatment defaulting. 
Some patients reported to have stopped taking their treatment because of some drug related side-
effects. These findings are in line with a study conducted in Botswana by Weiser et al. (2003) 
which indicated that side-effects pose a major barrier to treatment adherence. According to the 
latter study 12% of the participants claimed to have missed their treatment because of side-
effects while 51% claimed to have experienced some treatment side-effects. A qualitative study 
done in three countries, namely; Botswana, Tanzania and Uganda, it was found that treatment 
side-effects, amongst others, contribute to non-adherence (WHO, 2006). A study conducted by 
Peltzer et al. (2010) indicated in a period of six months 4.6% of the participants had temporarily 
suspended treatment and 0.6% had changed ARVs because of side-effects. This current study 
found that patients who were taking a combined treatment regimen, ARVs together with TB 
treatment, found it difficult to complete their treatment. According to Maskew, MacPhail, 
Menezes and Rubel (2007) compliance is made difficult by multiple adverse side-effects 
associated with the drugs as well as interactions with other chronic medications. Similarly a 
study conducted by Munro et al. (2007a) demonstrated the burden that ARVs adds on TB 
treatment. Treatment side-effects as a barrier to treatment adherence have been reported in 
various studies (Ware et al., 2009; Maskew, MacPhail, Menezes & Rubel, 2007; Mills et al., 
2006). Some ARV regimens are considered to be complicated due to a high pill burden. Trotta 
and co-workers (cited by Maskew, MacPhail, Menezes & Rubel, 2007) reported that patients on 
protease inhibitors (PI) were the poorest adherers and their main reason for non-adhering were 
vomiting and sexual dysfunction.  
 
5.14 Treatment fatigue 
According to Munro et al. (2007a) the attitude of patients on ARVs has been found to have a 
negative influence on treatment defaulting. In this current study patients said they had defaulted 
treatment because of feeling tired of having to take combined treatment for TB and ARVs. Some 
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patients claim to have defaulted treatment because they find it difficult to swallow the pills. 
Some participants say that the pills are big and one said she gets a sensation that the pills are 
going to get stuck in her throat. Some participants claim they force themselves to take the pills 
and sometimes they just decide not to take them. According to the WHO (2006) some studies 
reported ARV users often desire to take a drug holiday since ART is a lifelong treatment, and 
patients therefore become weary of taking medications every day. According to Osterberg and 
Blaschke (2005), 11% of the respondents in a questionnaire survey said they had decided to omit 
the doses. 
 
Mills et al. (2006) state that some patients are non-adherent due to, for example, doubt; not being 
able to accept their HIV status; lack of self-worth; uncertainty of long term effects and some 
unwanted changes to body image. According to the MOHSS (2007a) it is important to do 
treatment readiness assessment before starting a patient on ART. A patient’s willingness and 
ability to take long term treatment are vital aspects of the assessment. According to the theory of 
planned behavior the intention to perform certain behavior is influenced by the attitude towards 
the action thus intending to adhere to taking ARVs is influenced by a patient’s negative attitude 
about the treatment or of being tired taking  the medications (Armitage & Conner, 2001). HCPs 
should therefore use this theory when exploring factors that contribute to patients defaulting 
ART and this would require an assessment of a patient’s readiness to start ARVs. 
 
5.15 Conclusion  
This chapter discussed the findings of the study with reference to what has been reported in the 
literature. The study findings are consistent with other studies identifying social, personal, health 
service, socio-economic, workplace, as well as treatment related factors, as contributing to non-
adherence. 
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CHAPTER 6: RECOMMENDATIONS AND CONCLUSION 
 
6.1 Introduction 
In this chapter the research findings are summarized and presented. Conclusions are drawn and 
recommendations are made. Further research topics are recommended to address the identified 
factors that contribute to ARVs defaulting in the Oshakati district. 
 
6.2 Summary of findings 
The purpose of the study was to explore factors that influence adherence to ART among patients 
at the Oshakati State Hospital in the Oshana region, which is a rural area in Namibia, and to 
propose appropriate interventions.  
 
6.2.1 Religious, cultural, family and community related factors 
In this study religious and cultural beliefs were found to influence defaulting. Lack of family 
support has led to an unavailability of treatment supporters who live near/with the patients and 
this in turn led to a lack of encouragement for patients to continue with their ARV treatment 
hence non-adherence. Furthermore, discrimination and stigmatizing behaviors and attitudes from 
family members, as well as from the community, towards HIV /AIDS patients were mentioned to 
be contributing to non-adherence. 
 
6.2.2 Patient related factors 
Poor knowledge/understanding and lack of information about HIV/AIDS and ARVs were found 
to have negatively impacted on ARVs adherence. However forgetfulness was found to be the 
leading factor that contributed to non-adherence. The study highlighted alcohol intake, illiteracy, 
and unplanned travels, to have all contributed to defaulting. Moreover the study also found 
treatment defaulting to have been influenced by lack of patient commitment to treatment. 
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6.2.3 Health service related factors 
It is highlighted in the study that poor patient provider relationship, as well as attitudes of health 
providers, contributed to non-adherence. Poor organization at the clinic is mentioned to have 
contributed to long waiting times and eventually treatment defaulting. Moreover, shortage of 
staff led to long queues and overcrowding at the clinic and these were found to have influenced 
defaulting. Others reported to be satisfied with the heath service. Long travelling distances to the 
health facility and floods during the rainy season in the region were identified as barriers to 
adherence of ART.  
 
6.2.4 Socioeconomic factors 
Unemployment was found to be the major contributing factor to poor adherence since a lack of 
income results in lack of food as well as no funds to cover transport costs to attend the clinic. 
 
6.2.5 Work place related factors 
Poor employers’ support was reported to contribute to defaulting behaviors as some of the 
participants’ claim they were denied permission to go for their follow up treatment; some 
claimed they were followed to the clinic by their employers and were made to take leave without 
being attended to at the clinic. Some participants claim that money was deducted from their 
salaries after spending the whole day at the clinic.   
 
6.2.6 Treatment related factors 
The study highlighted treatment side-effect and treatment fatigue, as being some factors that led 
to defaulting. 
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6.3 Conclusion 
The goal of adherence to antiretroviral treatment is to improve and prolong the lives of those 
who are on the treatment.  This goal can only be achieved if patients on ARVs adhere to the 
treatment. It is therefore very important that counsellors provide adherence counselling properly 
in order to enhance adherence to antiretroviral treatment.  
 
Based on the findings of this study several interrelated factors were found to contribute to non-
adherent behaviour at the selected health facility in the Oshakati district. This study highlighted 
spiritual beliefs as a contributory factor as some patients stopped taking their treatment in solidarity 
to their faith or in favour of traditional medicine. Furthermore stigma and discrimination led to some 
participants not disclosing their HIV status which meant they accessed treatment at clinics far from 
their homes and in some instances participants feared that disclosure of their status could result in 
them being rejected by their respective partners which in turn influenced adherence negatively. 
Alcohol abuse and forgetfulness were amongst the factors reported to have contributed to non-
adherent behaviour. Illiteracy as well as lack of knowledge about the treatment regimen were barriers 
that could be linked to personal and health service factors. This link thus shows it has negative 
implications for patients on the ARVs programme since it reflects on the quality of health provided 
to the clients which in turn contributes to treatment defaulting. Additionally, the link between socio-
economic and health factors impacts negatively on patients’ ability to access care. Furthermore, lack 
of integrating the ARV programme into the normal health services has created stigma from the 
society.  
 
In view of findings of this study it is evident that there should be an holistic approach in the 
management of HIV/AIDS in order to address all these factors and to reduce the defaulting rate. This 
researcher is of the opinion that the policy makers, as well as other authorities, should utilize the 
findings of the study and come up with programmes that would ensure ARVs adherence. 
 
6.4 Recommendations 
The following recommendations are made based on various issues that emerged from the study. 
6.4.1 Training  
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  Training manuals on aspects contributing to adherence should be compiled. 
 Continuous in-service training for health-care workers on customer care, professionalism 
and on the developments concerning HIV/AIDS adherence should be provided. 
  In-depth training of community counsellors on the basic knowledge of HIV/AIDS, drug 
literacy and adherence counseling, should be provided.  
 The nurse training curricula could also be reviewed to evaluate the inclusion and 
adequacy of content in customer care and ARVs.   
 A follow-up system should be designed that will enable speedy identification of   patients 
who are not adhering to their ARV treatment programme.  
6.4.2 National HIV/AIDS programme 
 The national HIV/AIDS programme should develop practical guidelines, such as 
decentralizing of ARVs centers to clinics closer to the communities to reduce long 
distances traveling and minimize transport costs so as to reduce the non-adherence rates 
in the regions. 
 HIV/AIDS needs to be integrated into normal health care services to curb stigma and 
discrimination in the community as well as at the health facility. 
 Treatment guidelines that are in use should be revised and improved on. 
6.4.3 Health education 
 Health education of HIV/AIDS patients as well as the community members should focus 
on how the disease is transmitted, how it is prevented, the side-effects of treatment and 
the importance of treatment adherence. 
 Educational pamphlets on HIV/AIDS, treatment side-effects and the importance of 
compliance should be provided so that all citizens can readily access the information. 
 On-going community education on the basic knowledge of ARVs, treatment side-effects, 
the importance and functions of treatment supporter, should be implemented. 
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 Involvement of patients in the decision making process regarding their treatment should 
be actively promoted and implemented.  
 Resources should be allocated for the design and publishing of culturally acceptable 
educational pamphlets on ARV adherence, in the local languages, for dissemination in 
the community. 
 Patients’ values as well as religious beliefs should be considered when developing 
compliance strategies. 
6.4.4 Literacy programs 
 More literacy programs need to be developed and implemented in all villages; 
community members should be encouraged to join such programs in order to improve the 
literacy level in the area. 
6.4.5 Health workers 
 Patient-provider relationships should be improved by creating and maintaining a non-
judgmental therapeutic environment as well as showing respect and empathy towards 
patients. 
 A good relationship between patients and health-care workers is highly encouraged. 
 Health workers should collaborate with the community based organizations in promoting 
adherence to ARV treatments. 
  Community members should be motivated and requested to accept the responsibility of 
being treatment supporters of their HIV/AIDS infected relatives. 
 The involvement of all multidisciplinary teams to assist the clients to adhere to ARV 
treatment should be encouraged.  
 The number of the nurses and pharmacist assistants should be increased to attain quality 
of adherence services as well as to conduct outreach services. 
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6.4.6 Provision of social grant  
 The government should provide grants where appropriate to assist the clients to meet 
dietary adherence requirements. 
6.4.7 Out-reach services 
 The Ministry of Health and Social Services should provide transport for ARV outreach 
programs; during the rainy seasons when there are floods a helicopter should be provided 
to reach inaccessible places. 
 Conduct monthly outreach services. 
6.4.8 Employers’ involvement in the HIV/AIDS care 
 The rights of the patients need to be protected at work; patients should have the right to 
access treatment without fear of money being ducted from their salaries or being fired. 
Therefore there is a need to develop workplace policy and programs. 
6.4.9 Nutrition programme 
 The government should provide food to unemployed people who are on ART. 
6.5 Recommendations for further research 
In line with the findings in this study the researcher recommends that further research be 
conducted into the following aspects: 
 The impact of religious and cultural beliefs on ARVs defaulting should be determined. 
 Nurses’ knowledge of the psychological and emotional management of patients on ARV 
treatments should be researched. 
 The effectiveness of employers’ support in ARVs management should be scientifically 
established.  
 The impact of combining the ARVs and TB service delivery department to identify the 
various degrees of stigma and discrimination that patients face should be researched. 
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6.6 Limitations of the study 
 
The study was limited to the recruitment criteria of the participants. Selection bias might 
have occurred because participants were selected with the help of the nurse together with 
the community counselor. This was however minimized as the researcher had the final 
say over the selection and the eligibility criteria were strictly adhered to when selecting 
the study participants. The study focused on one health facility in the country which 
means that findings from the study may be too specific to apply to other settings. The fact 
that the researcher is Chief Registered Nurse (supervisor) at the same hospital may have 
introduced bias in the study. Errors may have occurred during translation of the recorded 
interviews from Oshiwambo English language. 
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APPENDIX 1 
 
INTERVIEW GUIDE FOR ART PATIENTS 
 
1.Can you please tell me what are your experiences living with HIV and being on life-
long ART? 
Prompts: 
∙When did you found out that you are HIV positive? And how did it affect you? 
∙What challenges did you face since knowing your HIV status? 
∙What made you decide to go to the programme? 
∙How do you feel about it now?  
∙How does it affect your life being on life-long ART? 
 
2. Based on your experience what are the factors that can influence ones adherence to 
ARTS? 
Prompt: 
∙ Are you married? 
∙ Does partner your know about your HIV status?  
∙ Has your HIV status brought problems between your relationship and your partner or other 
family members?  
∙ Is your family aware that you are on ART? Are they helpful? 
∙ How is your family’s behavior towards you? Did you observe any changes?  
∙Did you receive any counseling before starting ATR? 
 
3. How do you experience coming for follow-up visits at the clinic? 
Prompt: 
∙What would like to see changed or improved in the clinic services? 
∙How do you find the service at the clinic? 
∙How do you feel about coming for your follow-up visits? 
∙Do you have to anything to say about the health care providers? 
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∙What discourages to or makes you feel like not coming for follow-up visits? 
 
4. How do you experience the people in the community now that you are on treatment? 
Prompt: 
 
∙Has their behaviors towards you changed?  
∙What are the things in the community that helps you to cope better with your problem and 
encourage you to live a positive life? 
∙What are the things in the community that discourages so much and makes it difficult for 
you to live a positive life? 
 
5.What do you think are the factors related to taking treatment that can that can 
contribute to poor adherence?  
Prompt: 
∙For how long now are you taking this treatment? 
∙How was the treatment at first? 
∙Was the explanation about taking the medication clear to you? Did you understand 
everything at first? 
∙How do you feel about taking tablets every day? 
∙What helps you taking your tablets as prescribed?  
∙What makes it difficult for you to take your tablets 
∙ Have you tried to seek for medical help besides the health centers? 
 
6.If the patient works the following questions will be asked: 
∙How does working affect you taking your medicine? 
∙How do you find taking your medicine daily during working hours? Do you face 
difficulties? 
∙What helps you to take your medicine as prescribed at work? 
∙ What makes it difficult to take your medicine as prescribed at work? 
∙Are people at work aware that you are on ART? How are they treating you? 
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APPENDIX 2 
 
Interview guide for health workers/ nurses working at CDC clinic (Key informants). 
 
●How is your experience like with patients on ART? 
●What do you think encourage patients on ARTs to come for follow-ups visits to the clinic? 
●What do you think prevent them from coming for follow-up visits to the clinic? 
●What do you think are the factors/things that influence patients on ARTs from defaulting 
treatment 
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APPENDIX 3 
 
 
 
 
 
 
UNIVERSITY OF THE WESTERN CAPE 
School of Public Health 
Private Bag X17 ● BELLVILLE ● 7535 ● South Africa 
Tel: 021- 959 2809, Fax: 021- 959 2872 
Participant Information Sheet 
Dear participants 
Thank you for your willingness to hear and participate in this research project. The research is 
being conducted for a mini-thesis which is part of the requirement for a Master’s degree in 
Public Health (MPH) that I am completing at the University of the Western Cape. 
Title of the research 
Poor adherence amongst patients receiving antiretroviral therapy at Oshakati Intermediate 
Hospital, Namibia 
Purpose of the study 
 The project aims to explore the possible factors that influence adherence to Anti-Retroviral 
Treatment (ART) at the Communicable Disease Clinic (CDC) at Oshakati. The study outcome 
will therefore be used in making recommendations to the ministry of health and inform the 
implementation of the HIV/AIDS programme in Oshakati district.   
Who is the researcher? The study is being conducted by, Ms. Maria Bauleth, as a partial 
fulfillment of a Master’s Degree in Public Health, at the University of the Western Cape, S Study 
aim 
 This study aims to describe ART patients’ experiences of living with HIV/AIDS and explore 
factors that influence adherence to ART at Oshakati State Hospital, Communicable Disease 
Clinic (CDC) in the Oshana region, Namibia. 
Description of the research 
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The study will include interviews with nurses who are working with patients who are on ART at 
the CDC clinic at the Intermediate Hospital Oshakati. Furthermore, an interview schedule will be 
conducted whereby you will be asked about your experience of being on ART and what are the 
challenges influencing HIV treatment completion. It will take you about 45 minutes – 1 hour to 
complete .If you agree to be interviewed, please sign in the consent form provided. By signing, it 
will be understood that you have consented to participate in the project, and that you consent to 
publication of the results of the project with the understanding that anonymity will be preserved. 
Participation  
Your participation is voluntary and there is no penalty if you do not participate. If you feel 
uncomfortable during the interview you may omit the questions that make you uncomfortable or 
you may withdraw from the study completely without providing any reason for your withdrawal. 
Should you wish to withdraw please simply not answer any further questions you can withdraw 
anonymously at any time during the interview. However, I will appreciate it very much if you 
participate. You will be given refreshments at the end of the interview as a token of my 
appreciation of your participation. 
Benefits and cost from the study 
You may not get direct benefits from this study. However, the results of this study will be used in 
making recommendations and inform the implementation of HIV/AIDS programs in the 
Oshakati district. There are no costs for participation in this study other than the time that will be 
spent in interviewing you. 
What will be done to ensure confidentiality? 
 This is an entirely anonymous interview, and so your responses will not be identified with you 
personally in any way.   To ensure security, the audio recorded tapes will be kept in a locked 
cupboard and key. They will be destroyed after data entry. Data will be stored electronically in a 
database on a secured server and access is restricted by password to the researcher. 
Questions  
Should you have further question or concerns regarding your participation in this study, please 
contact me as follows: 
Maria F. Bauleth 
 E-mail: bauleth@iway.na 
Cell: +264811285934 
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Telephone at work +264 65 2233000 
Or my supervisor 
Brian Van Wyk 
University of the Western Cape 
Private Bag X17, Belville 7535 
Telephone: (021)959-2173 
Cell: 0829110904                              
 E-mail:schaay@uwc.ac.za or bvanwyk@uwc.ac.za 
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APPENDIX 4 
UNIVERSITY OF THE WESTERN CAPE 
School of Public Health 
Private Bag X17 ● BELLVILLE ● 7535 ● South Africa 
Tel: 021- 959 2809, Fax: 021- 959 2872 
 
 
CONSENT FORM 
Title of Research Project: Poor adherence amongst patients receiving antiretroviral therapy at 
Oshakati Intermediate Hospital, Namibia 
 
If you choose to participate in the study, your signed consent is required before you proceed for 
the interview. By signing you have agreed to the following: the study has been described to me 
in language that I understand and I freely and voluntarily agree to participate. My questions 
about the study have been answered. I understand that my identity will not be disclosed and that I 
may withdraw from the study without giving a reason at any time and this will not negatively 
affect me in any way.   
Participant’s name……………………….. 
Participant’s signature………………………………. 
Researcher‟s signature ………………………   
 
Date……………………… 
Should you have any questions regarding this study or wish to report any problems you have 
experienced related to the study, please contact the study coordinator: 
Study Coordinator’s Name: Brian van Wyk 
Private Bag X17, Belville 7535 Telephone: (021)959-2173 Cell: 0829110904 
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APPENDIX 5&6 
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